Adult Medicine Ambulatory Care Cardiology Central Nervous System Clinical Administration Critical Care Drug Information Education and Training

Emergency Medicine Endocrine and Metabolism Geriatrics GI/Liver/Nutrition Global Health Health Outcomes Hematology/Oncology HIV

Immunology/Transplantation Infectious Diseases Nephrology Pain and Palliative Care Pediatrics Perioperative Care PK/PD/PG Women’s Health

Introduction (recent activities, etc.)

Since its inception in 1999, the ACCP Adult Medicine PRN (AMED) has become one of the largest PRNs. We have members practicing in a variety of inpatient and outpatient settings, as well as in academia and the pharmaceutical industry. AMED consists of practitioners, residents, and students who share interest in shaping the practice of adult medicine through research and practice.

At the 2015 ACCP Global Conference, be sure to attend the AMED and Ambulatory Care PRN combined focus session. This program is an application-based activity covering Transitions of Care Management: Best Practices. After attending this session, you will be able to better strategize transitions of care medication reconciliation and patient education into the workflow at your practice site.

The AMED committees have been busy all year: the Archives Committee has been revising online content to ensure that the content and format are best suited to our members. The Training and Travel and Nominations committees have been reviewing applications for student, resident, and practitioner awards to be given at the 2015 Global Conference. The PBRN Research Committee has developed a collaborative project being reviewed by the ACCP Research Institute – more details to be discussed at the 2015 Global Conference. Be sure to attend the AMED PRN business meeting and networking forum at the 2015 Global Conference—we want you to be involved, too!

Promotions

• Renee Koski: Merit Promotion, following her promotion to Professor
• Sharon See: Clinical Professor at St. John’s University College of Pharmacy and Health Sciences
• Mate Soric: Associate Professor, Northeast Ohio Medical University College of Pharmacy
• Jon Wietholter: Associate Professor

Awards

• Rebeccah J. Collins: Received the VCU School of Pharmacy Preceptor of the Year Award
• Onor Ifeanyi: 2015 AACP Walmart Scholars Program Faculty Mentor
• Jacqueline L. Olin: 2015 Wingate University Graduate Faculty Member of the Year
• Mate Soric: P4 Preceptor of the Year, Northeast Ohio Medical University College of Pharmacy

Grants

• Jon Wietholter. Coinvestigator of a five-person team that was awarded a $1.39 million grant for 3 years from HRSA for a project titled “Interprofessional Collaboration for Vulnerable Acute Care Patients: An Academic-Service Partnership”

Publications

• Toussaint-Miller K, Andres J. A special touch: treatment considerations for unique patient populations with HCV genotype 1 infection. Ann Pharmacotherpy. Published online: 2 July 2015. Available at http://aop.sagepub.com/content/early/2015/06/24/1060028015592015.full.pdf+html.
• Okogbaa JI, Onor IO, Arije OA, Harris MB, Lillis RA. Phenytoin-induced purple glove syndrome: a case report and review of the literature. Hosp Pharm 2015;50:391-5.
• Smith A. Book chapters published in Patient Assessment in Pharmacy Practice, 3rd ed. Philadelphia: Wolters Kluwer, 2016: (1) Chapter 14. Gastrointestinal system. 255-75. (2) Chapter 15. Hepatic system. 276-92.
• Arterburn D, Johnson EJ, Butler MG, Fisher D, Bayliss E. Predicting 90-day mortality after bariatric surgery: an independent, external validation of a prognostic risk score. SOARD 2014;10:774-9.
• Arterburn D, Powers JD, Toh S, Polsky S, Butler MG, Dickman Portz J, Donahoo WT, Herrinton L, Williams R, Vijayadeva V, Fisher D, Bayliss EA. Comparative effectiveness of laparoscopic adjustable gastric banding versus laparoscopic gastric bypass in 10 health systems. JAMA Surg 2014;149:1279-87.
• Benitez GV, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Kimes TM, Butler MG, Karter AJ, Steiner JS, Newton K, Morales LS, Pathak RD, Thomas A, Reynolds K, Kirchner HL, Waitzfelder BE, Lafata JE, Adibhatla R, Xu Z, O’Connor PJ. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care 2015;38:905-12.
• Feigelson HS, Carroll NM, Weinmann S, Habel L, Haque R, Butler MG, Waitzfelder BE, Yu C, Wrenn MG, McGlynn EA. Treatment patterns for ductal carcinoma in-situ (DCIS) from 2000-2010 across six integrated health plans. Springer Plus. 2015;4:24. eCollection 2015.
• Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A. Asthma treatments and mental health visits after a Food and Drug Administration label change for leukotriene inhibitors. Clin Ther 2015 Apr 25. [Epub ahead of print]
• Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O’Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Elston-Lafata J, Butler MG, Kirchner HL, Ph.D., Thomas A, Steiner JF. Trends in diabetes incidence, 2006-2011, in seven million insured adults: the SUPREME-DM project. Am J Epidemiol 2015;181:32-9.
• Reynolds K, Butler MG, Kimes TM, Rosales AG, Chan W, Nichols GA. Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol 2015 May 9.
• Schmittdiel JA, Adams AS, Dyer W, Beals J, Henderson W, Desai J, Morales LS, Nichols GA, Lawrence JM, Waitzfelder B, Butler MG, Pathak R, Hamman R, Manson S, Steiner JF. Diabetes care and outcomes for American Indians and Alaska Natives in commercial integrated delivery Systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. BMJ Open Diabetes Res Care 2014;2:e000043.
• Schroeder EB, Powers JD, O’Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, Lafata JE, Reynolds K, Thomas A, Waitzfelder BE, Steiner JF; SUPREME-DM Study Group. Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. J Diabetes Complications 2015 Apr 16. [Epub ahead of print]
• Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;2:161-6.
• Wu AC, Li L, Fung F, Kharbanda EO, Larkin EK, Vollmer WM, Butler MG, Miroshnik I, Rusinak D, Davis RL, Weiss ST, Lieu TA. Leukotriene inhibitors may be more effective than inhaled corticosteroids in preventing asthma-related exacerbations. J Allergy Clin Immunol 2014;2:607-13.
• Bright DR, Adams AJ, Ulbrich TR, Soric MM. Coaching for success: a residency search primer and update for preceptors and faculty. Hosp Pharm 2015;50:467-76.
• Bright DR, Adams AJ, Ulbrich TR, Soric MM. Mentoring residency candidates: avoiding misinformation and employing best practices. Innov Pharm 2015;6:1-5.
• Treadway S, Helmer RS, Farland MZ, Ray SM. A pilot study to assess patient adherence to new chronic medications following the use of a novel adherence tool and individualized counseling. J Pharm Technol April 30, 2015.
• Wargo KA, McCreary EK, Englism TM. Vancomycin combined with clindamycin for the treatment of acute bacterial skin and skin-structure infections. Clin Infect Dis. Published online: 16 June 2015.

New 2015 ACCP Fellows

• Eli N. Deal
• Dianne W. May

Other Notable Achievements

• Beth Resman-Targoff. Optimizing clinical outcomes in rheumatoid arthritis therapy. Invited talk at: American Pharmacists Association Annual Meeting and Exposition; March 30, 2015; San Diego, CA.
• Beth Resman-Targoff. Appointed to the American College of Rheumatology Quality of Care Committee as a representative of the Association of Rheumatology Health Professionals. The only pharmacist serving on that committee
• April Smith: Invited faculty/speaker at the American Society for Metabolic and Bariatric Surgery (ASMBS) Weekend Meeting; June 25–28, 2015; Las Vegas, NV. Presentations: (1) Pharmacological Treatment of Obesity; (2) Perioperative Pharmacology in the Bariatric Surgery Patient: Who, What, Where, Why All the Prep?

Introduction

This has been another busy year for the Ambulatory Care PRN. Each of the committees has been hard at work to fulfill the charges outlined for the 2014–2015 year. The Education Committee has been working to schedule programming for the 2015 Global Conference, and the Budget Committee has been working closely with each committee to allocate funds as necessary. The Communications Committee published a newsletter in the spring and will publish a fall newsletter before the Global Conference, and the members are currently updating the Resource Guide and preparing a poster for the Global Conference. The Communications and Resident committees have been working together to increase the PRN’s activity on social media by posting weekly topics for discussion. The Advocacy Committee has been working diligently to improve communication with the PRN to provide updates on ACCP’s efforts at the federal level regarding provider status, and they sent a template to the PRN encouraging communication with the state legislators. The Membership Committee has been working to improve members’ awareness of PRN benefits, as well as to fund members’ ACCP Academy Certificate program registration and the Innovation Grant. The Nominations Committee worked to identify members for open officer positions for 2015–2016, while the Research and Scholarship Committee decided to fund two 50% scholarship for members to attend the MeRIT program. The Resident and Student committees are planning to help fund five Travel Awards to the Global Conference and are working to improve networking with students, residents, and fellows. Overall, the members of the PRN have been very active this year and have continued to improve the PRN as a whole.

Promotions

• Emily McCoy Armstrong: Associate Clinical Professor, Auburn University Harrison School of Pharmacy
• Ginelle Bryant: Associate Professor, Drake University College of Pharmacy and Health Sciences
• Kira Harris: Associate Professor, Wingate University
• Molly Graham Minze: Associate Professor, Texas Tech University Health Sciences Center School of Pharmacy
• Karen Gunning: Interim Department Chair of Pharmacotherapy, University of Utah College of Pharmacy
• Diana Isaacs: Clinical Associate Professor, Chicago State University College of Pharmacy
• Renee Koski: Merit Promotion
• Ann Philbrick: Associate Professor, University of Minnesota
• Matthew Pitlick: Associate Professor, St. Louis College of Pharmacy
• Krystal Riccio: Associate Professor of Pharmacy Practice, Roseman University of Health Sciences
• Mate Soric: Associate Professor, Pharmacy Practice Northeast Ohio Medical University College of Pharmacy
• Ashley Vincent: Clinical Associate Professor of Pharmacy Practice, Purdue University

Awards

• Debra Barnette: APhA Pinnacle award – 2015 Group Practice—Health System—Corporation Award; The Ohio State University College of Pharmacy and Division of General Internal Medicine. (Stuart Beatty, Pharm.D., Kelli Barnes, Pharm.D., Laura Hall, Pharm.D., Debra Barnette, Pharm.D.)
• Catherine A. Bourg: Teacher of the Year 2015, University of Georgia College of Pharmacy
• Kajua B. Lor: Student National Pharmaceutical Association Advisor of the Year 2015
• Nicole Slater: Auburn University Harrison School of Pharmacy Hargreaves Award and Student Advocate Award

Grants

• Catherine A. Bourg: UGA College of Pharmacy FACT grant (internal, $2000) for development and implementation of video enhanced case-based learning modules
• Tyler Harris Gums, Pharm.D.: ASHP New Investigator Grant
• Celia Lu: HRSA-15-054 Primary Care Training and Enhancement Program
• Cory Nelson and Kyle Turner: “Improving Transitions of Care Through Medication Management” grant from the Cardinal Health Foundation, $45,000
• Sweta Patel: Patel S, Shogbon A, Klein C, Ryan G. “A Step-wise Approach to Developing Information Gathering Skills Necessary to Create Patient-Specific Care Plans – Focus on Third Professional Year.” 2015 Mercer CATAL Grant, $1340
• Evan Williams: NACDS Foundation Grant – $20,000

Publications

• Brill SB, Barnette D. The use of pharmacogenomic testing in the management of adolescent depression. Accepted for publication by American Academy of Pediatrics (SOYP Newsletter).
• Bourg CA, May DB. Peptic ulcer disease. In: Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles & Practice, 4th ed. New York: McGraw-Hill, 2016. In press.
• Broders J. Diving for PURLS: increased risk for pyloric stenosis with macrolides in newborns and with peripartum use. Evid Based Pract 2015;18:4.
• Broders Jarrett J. Diving for PURLS: mindfulness to reduce depression. Evid Based Pract 2015;18:5.
• Corbo J, Broders Jarrett J. Diving for PURLS: not so sweet: honey for acute cough in children. Evid Based Pract 2015;18:4.
• Koenig M, Broders Jarrett J. Diving for PURLS: allopurinol: an old drug revitalized for CKD? Evid Based Pract 2015;18:5.
• Essex MN, O’Connell MA, Behar R, Bao W. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study. Int J Rheum Dis 2015 May 20. [Epub ahead of print]
• George CM, Brujin LL, Will K, Howard-Thompson A. Management of blood glucose with noninsulin therapies in type 2 diabetes. Am Fam Physician 2015;92:27-34.
• Hartzler ML, Ballentine J, Kauflin M. Results of a survey to assess residency preceptor development methods and precepting challenges. AJHP 2015;72:1305-14.
• Hester EK, Carroll DG, Kelley KW, Westrick SC. Implementation and evaluation of evidence-based patient care application during a primary care advanced practice experience. Curr Pharm Teach Learn 2015;7:324-31.
• Shah BM, Mezzio DJ, Ho J, Ip EJ. Association of ABC (HbA1c, blood pressure, LDL-cholesterol) goal attainment with depression and health-related quality of life among adults with type 2 diabetes. J Diabetes Complications. 2015 Apr 24. [Epub ahead of print]
• Kugler AJ, Fabbio KL, Pham DQ, Nadeau DA. Inhaled Technosphere insulin: a novel delivery system and formulation for the treatment of type 1 and type 2 diabetes mellitus. Pharmacotherapy 2015;35:298-314.
• Lor KB, Moua S, Ip EJ. Frequency and perceptions of herbal medicine use among Hmong Americans: a cross sectional survey. J Immigr Minor Health. 2015 Mar 18 [Epub ahead of print]
• Lor KB, Truong J, Ip EJ, Barnett MJ. A randomized prospective study on outcomes of an empathy intervention among second-year student pharmacists. Am J Pharm Educ 2015;79:18.
• Young C, Lor KB, McCarter G, Ignoffo R. Survey of California pharmacists’ awareness of and readiness for the new authorities granted by SB493: a pilot study. CPhA J. In press.
• Kelley KW, Carroll DG, Meyer A. A review of current treatment strategies for gestational diabetes mellitus. Drugs Context 2015;4:212282.
• Prasad-Reddy L, Isaacs D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context 2015;4:212283.
• Schartel A, Rochester C. Novel oral anticoagulants: strategies for optimizing patient outcomes. Pharmacy Practice News 2015;42:8-12.
• Slater NA, Rager ML, Havrda DE, Harralson AF. Genetic variation in CYP2R1 and GC genes associated with vitamin D deficiency status. J Pharm Pract June 2, 2015.
• Bright DR, Adams AJ, Ulbrich TR, Soric MM. Coaching for success: a residency search primer and update for preceptors and faculty. Hosp Pharm 2015;50:467-76.
• Bright DR, Adams AJ, Ulbrich TR, Soric MM. Mentoring residency candidates: avoiding misinformation and employing best practices. Innov Pharm 2015;6:1-5.
• Thurston MM, Bourg CA, Phillips BB, Huston SA. Impact of health literacy level on aspects of medication nonadherence reported by underserved patients with type 2 diabetes. Diabetes Technol Ther 2015;17(3).
• Winder M, Johnson J, Planas L, Crosby K, Gildon B, Oberst-Walsh L. Impact of pharmacist-led educational and error notification interventions on prescribing errors in a family medicine clinic. J Am Pharm Assoc 2015;55:238-45.
• Yuet WC, Khine H, Ahmad Z. Statin-associated adverse events. Clin Med Insights Ther 2015;7:17-24.

New ACCP Fellows

• Debra Barnette: The Ohio State University
• Daniel Riche: University of Mississippi

Other Notable Achievements

• Celia Lu: ACCP Mentored Research Investigator Training (MeRIT) Program Mentee
• Christie Schumacher: Board Certification in Ambulatory Care Pharmacy
• Erin L. Thompson, University of Findlay College of Pharmacy: Board Certification in Ambulatory Care Pharmacy
• Kim Thrasher: Panelist for Family Medicine for America’s campaign, “Health Is Primary”
• Marquita Winder: Certified Diabetes Educator
• Deniz Yavas: Board Certification in Ambulatory Care Pharmacy

Presentations

• Kelly Hester: Ask the experts: practice issues related to the management of patients with HIV in the ambulatory care setting. American Society of Health-System Pharmacists. CE Webinar Presentation. March 5, 2015.

Poster Presentations

• Carroll DG, Armstrong EM, Gaillard, PR, Bellone J. Student comfort and perception of women’s health topics using lecture and TBL delivery methods. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 11–15, 2015; National Harbor, MD.
• Parrish K, Hester EK. Evaluation of appropriate statin therapy in HIV-infected patients in Central Alabama. Presented at: Alabama Society of Health-System Pharmacists Annual Meeting; May 31 – June 2, 2015; Pensacola Beach, FL. Second-place poster presentation
• Shah DM, Mezzio D, Ho J, Ip EJ. Impact of depression on ABC goal attainment & health-related quality of life among adults with type 2 diabetes. Presented at: ISPOR 20th Annual International Meeting; May 2015; Philadelphia, PA. [Poster awarded Finalist]
• Slater N, Shelton P, Marsh W. Examining pharmacy students’ critical thinking abilities in the context of their learning styles. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 11–15, 2015; National Harbor, MD.

Other

• Courtney E. Gamston: Graduated from residency at Auburn and started a faculty position at the Edward Via College of Osteopathic Medicine (VCOM Auburn) on July 1 as the Discipline Chair for Pharmacology
• Nicole Wegrzyn: Offered a position as PGY2 Nephrology Resident with Albany College of Pharmacy and Health Sciences after spending 2 years as an Assistant Professor at Pacific University Oregon School of Pharmacy. As Assistant Professor, received Runner-Up for Teacher of the Year for AY 2014–2015

Promotions

• Lindsay Davis: Associate Professor at Midwestern University College of Pharmacy – Glendale
• Rob DiDomenico: Clinical Professor at University of Illinois, Chicago
• Paul Dobesh: Full Professor at the University of Nebraska
• James Hollands: Vice Chair, Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy at University of the Sciences
• Antoine Jenkins: Cinical Associate Professor at the Chicago State University – College of Pharmacy

Awards

• Sally Arif: 2015 Teacher of the Year by the Midwestern University Chicago College of Pharmacy Class of 2017
• Lindsay Davis: Inaugural Outstanding Educator Award from Midwestern-Glendale’s Class of 2015

Grants

• Sally Arif: “Cardiovascular and Diabetes Screening Program for the Middle-Eastern Community of Chicagoland.” American Heart Association Community Innovation Program. July 1, 2014.
• James Tisdale: “Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes.” American Heart Association Midwest Affiliate. July 1, 2015 – June 30, 2017.

Publications

• DeJongh B, Birkeland K, Brenner M. Managing comorbidities in patients with chronic heart failure: first, do no harm. Am J Cardiovasc Drugs 2015 Apr 3.
• Hale G, Brenner M. Atomoxetine for orthostatic hypotension in an elderly patient over 10 weeks: a case report. Pharmacotherapy. Accepted for publication.
• Hale G, Brenner M. Risks and benefits of low molecular-weight heparin and target-specific oral anticoagulant use for thromboprophylaxis in medically ill patients. Am J Cardiovasc Drugs 2015 May 9.
• Poon JL, Brenner AC, Brenner MJ. Comparison of amiodarone compliance monitoring: usual care, electronic prescribing template and pharmacist-managed clinic. J Pharm Pharmacol 2014;2:621-6.
• Arterburn D, Johnson EJ, Butler MG, et al. Predicting 90-day mortality after bariatric surgery: an independent, external validation of a prognostic risk score. SOARD 2014;10:774-9.
• Arterburn D, Powers JD, Toh S, Polsky S, Butler MG, et al. Comparative effectiveness of laparoscopic adjustable gastric banding versus laparoscopic gastric bypass in 10 health systems. JAMA Surg 2014;149:1279-87.
• Benitez GV, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Kimes TM, Butler MG, et al. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care 2015;38:905-12.
• Feigelson HS, Carroll NM, Weinmann S, Habel L, Haque R, Butler MG, et al. Treatment patterns for ductal carcinoma in-situ (DCIS) from 2000-2010 across six integrated health plans. Springer Plus. 2015;4:24. eCollection 2015.
• Lu CY, Zhang F, Lakoma MD, Butler MG, et al. Asthma treatments and mental health visits after a Food and Drug Administration label change for leukotriene inhibitors. Clin Ther 2015 Apr 25. [Epub ahead of print]
• Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O’Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Elston-Lafata J, Butler MG, et al. Trends in diabetes incidence, 2006-2011, in seven million insured adults: the SUPREME-DM project. Am J Epidemiol 2015;181:32-9.
• Reynolds K, Butler MG, et al. Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol 2015 May 9.
• Schmittdiel JA, Adams AS, Dyer W, Beals J, Henderson W, Desai J, Morales LS, Nichols GA, Lawrence JM, Waitzfelder B, Butler MG, et al. Diabetes care and outcomes for American Indians and Alaska Natives in commercial integrated delivery systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study. BMJ Open Diabetes Res Care 2014;2:e000043.
• Schroeder EB, Powers JD, O’Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, et al.; SUPREME-DM Study Group. Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. J Diabetes Complications. 2015 Apr 16. [Epub ahead of print]
• Wu AC, Butler MG, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;2:161-6.
• Wu AC, Li L, Fung F, Kharbanda EO, Larkin EK, Vollmer WM, Butler MG, et al. Leukotriene inhibitors may be more effective than inhaled corticosteroids in preventing asthma-related exacerbations. J Allergy Clin Immunol 2014;2:607-13.
• Adams SM, Anderson K, Coons JC, et al. PGx Test2Learn^TM: advancing pharmacogenomics education in the core Pharm.D. curriculum through student personal genomic testing. Am J Pharm Educ 2015. In press.
• Verlinden NV, Coons JC. Disopyramide for hypertrophic cardiomyopathy: a pragmatic reappraisal of an old drug. Pharmacotherapy 2015. In press.
• DiDomenico RJ, Cavallari LH. Chapter 7: ischemic heart disease. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer JC, Dipiro JT, eds. Pharmacotherapy Principles & Practice, 4th ed. In press.
• Lose J, Dorsch MP, DiDomenico RJ. Differences in practice patterns between inpatient cardiology pharmacists with Board of Pharmaceutical Specialties Added Qualifications in Cardiology compared to pharmacists without this distinction. Hosp Pharm 2015;50:51-8.
• Jackevicius C, Rose A, Turakhia MP. Site-level variation in and practices associated with dabigatran adherence. JAMA 2015;313:1443-50.
• Lee JA, Lee CR, Reed BN, Plitt DC, Polasek MJ, Howell LA, Cicci JD, Tasca KE, Weck KE, Rossi JS, Stouffer GA. Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients. Pharmacogenomics 2015;16:303-13.
• Lillyblad MP. Dual angiotensin receptor and neprilysin inhibition in chronic systolic heart failure: understanding the new PARADIGM. Ann Pharmacotherapy 2015 Jul 14. [Epub ahead of print]
• Shore S, Ho PM, Lambert-Kerzner A, Glorioso TJ, Carey EP, Cunningham F, Longo L, Morrill AM, Ge D, Willett KC. Dosing of target-specific oral anticoagulants in special populations. Ann Pharmacotherapy 2015 June 23 [Epub ahead of print]
• Bomb R, Oliphant CS, Khouzam RN. Dual antiplatelet therapy after coronary artery bypass grafting in the setting of acute coronary syndrome. Am J Cardiol 2015;116:148-54.
• Rogers KC, Oliphant CS, Finks SW. Clinical efficacy and safety of cilostazol: a critical review of the literature. Drugs 2015;75:377-95.
• Rogers KC, Oliphant CS, Finks SW. Ischemic heart disease and acute coronary syndrome. In: Chyka PA, Boucher BA, Franks AS, Waddell JA, eds. The APhA Complete Review for Pharmacy, 11th ed. Washington, DC: American Pharmacists Association, 2015:267-97.
• Tisdale JE, Allen MR, Overholser BR, Jaynes HA, Kovacs RJ. Influence of zoledronic acid on atrial electrophysiological parameters and electrocardiographic measurements. J Cardiovasc Electrophysiol 2015;26:671-7.
• Mo Y, Yam FK. Recent advances in the development of antidotes for target specific oral anticoagulants. Pharmacotherapy 2015;35:198-207.

Posters/Abstracts Presented

• Baker WL, Coleman CI. Impact of ascorbic acid on post-cardiothoracic surgery atrial fibrillation and length of stay: a meta-analysis of randomized controlled trials. Presented at: European Society of Cardiology Congress 2015; August 30, 2015; London, UK.
• Baker WL, Gale AM, Gluck JA, Radojevic JA, O’Bara LF, Murphy AD, Dougherty J, Martin ST. Evaluation of a sirolimus/tacrolimus-minimization strategy in heart transplant recipients: can we avoid further nephrotoxicity? Presented at: Heart Failure Society of America 19th Annual Scientific Session 2015; September 26, 2015; Washington, DC.
• Reale MC, Witt BA, Riche DM, Baker WL, Peeters MJ. Development of critical thinking among health professions students: a meta-analysis of longitudinal studies. Presented at: American Association of Colleges of Pharmacy 2015 Annual Meeting; July 12, 2015; Washington, DC.
• Harrington R, Kumar VM, Zueger PM, Rigoni G, Atwood AM, Ochieng W, DiDomenico RJ, Touchette DR. Cost-utility analysis of angiotensin receptor-neprilysin inhibitor LCZ696 to ACE inhibitors for the treatment of chronic heart failure in the United States. Presented at: Association of Managed Care Pharmacy (AMCP) Nexus 2015; October 2015; Orlando, FL.
• Kim K, Lee TA, Ardati AK, Touchette DR, DiDomenico RJ, Walton SM. Comparative effectiveness of ticagrelor vs. prasugrel in patients with acute coronary syndrome. Presented at: 18th Annual International Society of Pharmacoeconomic and Outcomes Research (ISPOR) European Congress; November 2015; Milan, Italy.

Other Notable Achievements

• Brittany Florczykowski: Additional Qualifications in Cardiology
• Craig Lee: Fellow of the American Heart Association (FAHA)
• Mary Parker: Fellow of ASHP (FASHP)
• Christie Schumacher: Board Certified Ambulatory Care Pharmacist (BCACP)
• Azita Talasaz: Additional Qualifications

Introduction

The CNS PRN members have been very active during the past 6 months, receiving promotions, publishing scholarly work, receiving local and national awards, and completing advanced research education! Of note, we have one CNS PRN member, Dr. Cherry Jackson, who will be named an ACCP Fellow at the upcoming meeting! Way to go!

In addition, the CNS PRN Programming Committee has been collaborating with the Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN to develop an exciting joint focus session titled “An Update of Psychotropic Pharmacogenomics” for the upcoming ACCP Global Conference in beautiful San Francisco.

Promotions

• Klugh Kennedy: From Associate to Full Professor of Pharmacy Practice and Psychiatry

Publications

• Bishop JR, Reilly JL, Harris MS, Patel SR, Kittles R, Badner JA, Prasad KM, Nimgaonkar VL, Keshavan MS, Sweeney JA. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia. Psychopharmacology (Berl) 2015;232:145-54.
• Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther 2015;98:127-34.
• Najjar F, Owley T, Mosconi MW, Jacob S, Hur K, Guter SJ, Sweeney JA, Gibbons RD, Cook EH, Bishop JR. Pharmacogenetic study of serotonin transporter and 5HT2A genotypes in autism. J Child Adolesc Psychopharmacol 2015;25:467-74.
• Cates ME, Clark A, Woolley TW, Saunders A. Sleep quality among pharmacy students. Am J Pharm Educ 2015;79:9.
• Cates ME, Hogue MD, Woolley TW. Effects of actual participation in drug testing on the attitudes of first-year pharmacy students toward a mandatory drug testing program. Curr Pharm Teach Learn 2015;7:224-30.
• Cates ME, Jackson CW. Posttraumatic stress disorder. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program, 2015 Book 1. Neurologic and Psychiatric Care. Lenexa, KS: American College of Clinical Pharmacy, 2015:93-115.
• Chen JJ, Horne KE, Dutta AP. Faith-based colleges and schools of pharmacy in the United States: a taxonomic survey and results. Pharm Pharmacol Int J 2(2):00019.
• Dashtipour K, Chen JJ, Kani C, Bahjri K, Ghamsary M. Clinical outcomes in patients with Parkinson’s disease treated with a monoamine oxidase type-B inhibitor: a cross-sectional, cohort study. Pharmacotherapy 2015;35:681-6.
• Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity. Am J Phys Med Rehabil 2015;94:229-38.
• Dashtipour K, Johnson EG, Kani, C, Kani K, Hadi E, Ghamsary M, Pezeshkian S, Chen JJ. Impact of exercise on motor and non-motor symptoms of Parkinson’s disease: a pilot study. Parkinson’s Disease Vol 2015, Article ID 586378. http://dx.doi.org/10.1155/2015/586378.

Other Notable Achievements

• Todd Brackins: Will graduate from ACCP’s Research and Scholarship Academy
• Marshall E. Cates: Pharmacy Practice Faculty Member of the Year Award from McWhorter School of Pharmacy and the AACP Innovations in Teaching Award
• Jack J. Chen: Appointed as the American Academy of Neurology delegate to the 2015–2020 United States Pharmacopeial Convention
• Cherry W. Jackson: Newly designated ACCP Fellow
• Stephanie Nichols: Faculty Experiential Educator of the Year Award from Husson University School of Pharmacy.

The CADM PRN will host a focus session at the 2015 ACCP Global Conference on Monday, October 19, from 1:30 to 3:00 p.m. The session will address patient monitoring prioritization and productivity measurement necessary to grow and sustain pharmacy services. Learners will come away with practical tools that can be carried back and used to demonstrate the valuable work of pharmacy departments and their impact on patient care in the world of electronic health records. We look forward to seeing you there!

The Education Committee of the CADM PRN has produced a module for education representing an important topic for clinical administration members. Nitish Bangalore, clinical manager of St. Joseph’s Hospital, Froedtert & The Medical College of Wisconsin, created a module titled “Effective Professional Conversations.” This module will be available on ACCP’s ClinPharmEd.com later this year.

The CADM PRN Students and Residents Committee has held several meetings this year discussing topics of interest. In June, Curt Haas, director of pharmacy, University of Rochester Medical Center, gave a presentation on board certification. The committee is co-led by Tamara Malm, former PGY2 admin resident at Yale-New Haven Hospital, and Cindy Brasher, PGY2 admin resident at Mission Hospital in North Carolina. The group will host a meeting in September to discuss PGY1 and PGY2 admin and informatics residencies and announce the winner(s) of the student and resident travel stipends for the Global Conference in October. More details will be provided.

Dr. Tamara Malm will represent the CADM PRN as a facilitator during the Clinical Pharmacy Career Path Roundtable session at the upcoming Global Conference in San Francisco. This session will expose students, residents, and fellows to a variety of specialty career paths within clinical pharmacy.

The CADM PRN would like to congratulate the following newly elected officers:

• Chair-Elect: Venita Papillion, Director, Catholic Health Initiatives, Denver, CO
• Secretary/Treasurer: Elizabeth Michalets, Regional Asst. Dean of Clinical Affairs and Associate Professor, Mission Health System and UNC Eshelman School of Pharmacy
• Our former chair-elect and new chair is Angela Black Smith, director of pharmacy, N.C. Department of Health and Human Services.
• The roundtable session will be held on Sunday, October 18, from 2:15 p.m. to 4:00 p.m. The CADM PRN will hold its business meeting and networking forum on Monday, October 19, from 6:00 p.m. to 9:00 pm. PRN members and anyone interested in joining the CADM PRN are welcome to attend. There will be light refreshments followed by networking and planning for the new year.

The Critical Care PRN continues to be one of the largest PRNs within ACCP. During the past few months, the PRN has been working with the Society of Critical Care Medicine and the American Society of Health-System Pharmacists on updating the Position Paper on Clinical Pharmacy Services published in 2000. This group plans to have its updated Position Paper ready for review sometime in 2016. The PRN also approved funding for two of its members to attend the first-ever MeRIT program this year. The CC PRN will also conduct its second Professor Walk-Rounds for abstracts accepted to the ACCP Global Conference, and accepted member submissions may be selected for presentation of research during this venue. In addition, we would like to recognize the following individuals:

Promotions

• Kevin Anger: Manager, Investigation Drug Services at Brigham and Women’s Hospital, and Associate Professor at the MGH Institute of Health Professions
• Bryan Bishop: Assistant Professor at the University of Toledo College of Pharmacy
• Pamela Smithburger: Associate Professor of Pharmacy and Therapeutics at the University of Pittsburgh
• Jodi Taylor: Chair, Department of Pharmacy Practice at Union University School of Pharmacy

Awards

• Pamela Smithburger: 2015 University of Pittsburgh Institute for Clinical Research Education Award for Outstanding Thesis in Clinical Research
• Pamela Smithburger: 2015 Society of Critical Care Medicine, Clinical Pharmacy and Pharmacology Section Medication Safety Award, “A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical Intensive Care Units”
• Pamela Smithburger: 2015 Society of Critical Care Medicine 2015 Patient and Family Support Specialty Award for highest-scored abstract: Senior Author and Mentor
• Jodi Taylor: Faculty Preceptor of the Year (Local, Union University School of Pharmacy Class of 2015)

Grants

• Drayton Hammond: American Foundation for Pharmaceutical Education Research Scholarship

Publications

• Anger KE, Belisle C, Colwell MB, Dannemiller R, Alawadhi B, Wilkocki A, Szumita PM. Safety of compounded calcium chloride admixtures for peripheral intravenous administration in the setting of a calcium gluconate shortage.J Pharm Pract 2014;27:474-7.
• Forni AA, Chesnick M, Szumita PM, Anger KE, Averey KR, Scirica B. Evaluation of glucose management during therapeutic hypothermia at a tertiary academic medical center. Resuscitation 2015;89C:64-9.
• Gillis CM, Anger KE, Cotugno M. Enhanced responsibilities for pharmacy interns at a teaching hospital. J Am Pharm Assoc 2015;55:14-8.
• Gillis CM, Poyant JO, Degrado JR, Ye L, Anger KE, Owens RL Inpatient pharmacological sleep aid utilization is common at a tertiary medical center. J Hosp Med 2014;9:652-7.
• Reardon DP, Degrado JR, Anger KE, Szumita PM. Early vasopressin reduces incidence of new onset arrhythmias. J Crit Care 2014;29:482-5.
• Bishop BM. Antimicrobial stewardship in the emergency department: challenges, opportunities, and a call to action for pharmacists. J Pharm Pract 2015 Jun 1. [Epub ahead of print]
• Bishop BM. Involving pharmacy technicians and students in the emergency department to expand care provided by clinical pharmacists. Am J Health Syst Pharm 2015;72:993-4.
• Bishop BM. Potential and emerging treatment options for Ebola virus disease. Ann Pharmacotherapy 2015;49:196-206.
• Bishop BM. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Am J Health Syst Pharm 2014;71:1839-44.
• Bishop BM, Shumate L. Coping with death in the patient care setting. Am J Health Syst Pharm 2015;72:918-20.
• Brandt K, McGinn K, Quedado J. Low-dose systemic alteplase (tPA) for the treatment of pulmonary embolism. Ann Pharmacotherapy 2015 Apr 9. [Epub ahead of print]
• Flannery AH, Bachmeier H. Vancomycin-associated nephrotoxicity: unintentional consequences of a loading dose? [letter]. Crit Care Med 2015;43:e154.
• Flannery AH, Kruger PS. Point: should patients receiving statins prior to ICU admission be continued on statin therapy? Chest 2014;146:1431-3.
• Flannery AH, Winstead PS, Smith KM. Transforming the curriculum vitae as a new practitioner. Am J Health Syst Pharm 2014;71:2115-7.
• Kido K, Adams VR, Morehead RS, Flannery AH. Capecitabine-induced ventricular fibrillation arrest: possible Kounis syndrome. J Oncol Pharm Pract 2015 Apr 13. [Epub ahead of print]
• Hamilton LA, Lockhart NR, Crain MR. Candida glabrata and Candida tropicalis in an immunocompetent patient: a case report. J Pharm Pract 2015;28:284-7.
• Dickey SE, Mabry WA, Hamilton LA. Possible sulfamethoxazole/trimethoprim-induced pancreatitis in a complicated adolescent patient post-traumatic injury. J Pharm Pract 2015. In press.
• Elmore LK, Hamilton LA. Argatroban for the treatment of heparin-induced thrombocytopenia in end-stage renal disease and acute kidney injury. Tenn Med 2015:3:Article 3.
• Rinehart DR, Lockhart NR, Hamilton LA, et al. Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity (FEIBA). Crit Care Med 2015;43:e203-7.
• Kalabalik J, Rattinger G, Sullivan J et al. Use of non-vitamin K antagonist oral anticoagulants in special patient populations with nonvalvular atrial fibrillation: a review of the literature and application to clinical practice. Drugs 2015.
• Quidley AM. Collateral damage: balancing the risks and benefits of antimicrobial prophylaxis. Orthopedics 2015;38:281-2.
• Quidley AM, Kaplow R. Pharmacologic support following cardiac surgery. In: Hardin SR, Kaplow R, eds. Essentials in Cardiovascular Surgery, 2nd ed. Burlington, MA: Jones & Bartlett.
• Arnall J, QuidleyAM. The ins and outs of residency applications. Pharmacy Times 2015. Available at www.pharmacytimes.com/publications/career/2015/PharmacyCareers_May2015/The-Ins-and-Outs-of-Residency-Applications.
• Bookstaver PB, Quidley AM. Central nervous system in immunocompetent hosts. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program 2013-2015. American College of Clinical Pharmacy, 2015.
• Smithburger PL, Buckley MS, Sokol S, Culver MA, Lat I, Handler SM, Kirisci L, Kane-Gill SL. A multi-center evaluation of off label medication use and adverse drug reactions in adult medical intensive care units.Crit Care Med 2015. Accepted for publication.
• Hale GM, Kane-Gill SL, Groetzinger L, Smithburger PL. An evaluation of adverse drug reactions associated with antipsychotic treatment for delirium in the intensive care unit. Pharm Pract 2015.
• Kane-Gill SL, Rubin EC, Smithburger PL, Buckley MS, Dasta JF. The cost of opioid induced adverse drug events. J Pain Palliat Care Pharmacotherapy 2014;28:282-93.
• Kane-Gil SL, Smithburger PL, Williams EA, Felton MA, Wang N, Seybert AL. Published cases of adverse drug reactions: has the quality of reporting improved over time? Ther Adv Drug Saf 2015;6:38-44.
• Lyons P, Nery J, Rivosecchi R, Smithburger PL, Kane-Gill SL. Fentanyl induced hyperalgesia in acute pain management. J Pain Palliat Care Pharmacotherapy 2015. In press.
• Rivosecchi R, Kane-Gill SL, Svec S, Campbell S, Smithburger PL. Giving your patients M.O.R.E: the implementation of a non-pharmacologic protocol to prevent intensive care delirium. Intensive Care Medicine 2015. Submitted.
• Rivosecchi R, Smithburger PL, Svec S, Campbell S, Kane-Gill SL. Nonpharmacological interventions to prevent delirium: an evidence-based review. Crit Care Nurse 2015;35:39-49.

Other Notable Achievements

• Kevin Anger: MSHP Board of Directors ASHP Section of Clinical Scientists and Specialists Educational Steering Committee
• Kevin Anger: Board Certified Pharmacotherapy Specialist
• Mason Bucklin: Board Certified Pharmacotherapy Specialist
• Mason Bucklin: Secretary/Treasurer of ACCP EMED PRN
• Michaelia Cucci: Institutional (Cleveland Clinic) Tier 4 Caregiver Celebration
• Michaelia Cucci: ACCP Critical Care PRN – Chair of Research Committee and SCCM CCP – Co-chair of Programming Committee
• Alexander Flannery: Chair, Professional Practice Advisory Group (ASHP New Practitioners Forum)
• Leslie Hamilton: University of Tennessee Health Science Center SGAEC Excellence in Teaching Award
• Leslie Hamilton: AACP: Pharmacy Practice Section Award Committee Chair
• Drayton Hammond: President-Elect of the Arkansas Colleges of Clinical Pharmacy
• Sarah Maryon Hayes: “Best Pharm.D. Seminar Presentation.” University of Minnesota, Class of 2015 – Hayes SM. “Sedative Exposure Reduction via Patient-Controlled Sedation (PCS) in Critically Ill Ventilated Patients”
• Judith Jacobi: Master of Critical Care Medicine
• Judith Jacobi: President, American College of Clinical Pharmacy
• Julie Kalabalik: President of the Central Chapter of the New Jersey Society of Health System Pharmacists
• April Miller Quidley: Society of Critical Care Medicine Presidential Citation
• April Miller Quidley: North Carolina Association of Pharmacists – Health-System Pharmacy Practice Forum Liaison
• Samantha Say: Graduated from MSHA program
• Pamela Smithburger: Residency Program Director for PGY2 Critical Care Residency at the University of Pittsburgh
• Jodi Taylor: Appointed to ASHP Council on Therapeutics (2015–2016); currently serves as Chair of the Educational Programming Committee (Tennessee Society of Health-System Pharmacists)
• Jodi Taylor: Selected to serve as faculty adviser for the AACP Walmart Scholar Program

Introduction

The Drug Information PRN is looking forward to the ACCP Global Conference on Clinical Pharmacy in San Francisco. Our focus session this year, “Drug Information for the Busy Practitioners: Time-saving Tips for Finding and Evaluating Medical Literature,” is a presentation not to be missed. Two topics that will be covered are “Looking Beyond PubMed: Making the Most of Google Power Searching and Use of Grey Literature in Pharmacy Practice,” presented by Philip Gregory, Pharm.D., M.S., and “When Time Matters: Innovative Tools and Techniques to Evaluate the Quality of a Clinical Trial Quickly and Efficiently,” presented by Melissa Blair, Pharm.D., FCCP, BCPS.

In addition, please join us at our Drug Information PRN business meeting, where we will welcome in our new officers for 2015–2016: Dianne May, Pharm.D., BCPS (Chair), Andrew Abe, Pharm.D. (Chair-Elect), Janine Douglas, Pharm.D., BCPS (Secretary/Treasurer), and Cathy Ficzere, Pharm.D., BCPS (Immediate Past Chair).

Promotions

• Dianne May: Clinical Professor
• Jen Phillips: Associate Professor and Tenure
• Chris Wisniewski: Associate Professor

Awards

• Sherrill Brown: Kappa Epsilon National Fraternity Career Achievement Award
• Chris Wisniewski: SCCP Clinical Pharmacy and Outcome Sciences Excellence in Teaching Award

Publications

• Abe A, Hein D, Gregory P. Regulatory alerts for dietary supplements in Canada and the United States, 2005–13. Am J Health Syst Pharm 2015;72:966-71.
• American College of Clinical Pharmacy; McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy 2015;35:e39-50.
• Cruz JL, Brown JN. Safety risks with investigational drugs: pharmacy practices and perceptions in the veterans affairs health system. Ther Adv Drug Saf 2015;6:103-9.
• Cruz JL, Wolff ML, Vanderman AJ, Brown JN. The emerging role of tacrolimus in myasthenia gravis. Ther Adv Neurol Disord 2015;8:92-103.
• Wolff M, Cruz JL, Vanderman AJ, Brown JN. The effect of angiotensin II receptor blockers on hyperuricemia. Ther Adv Chronic Dis 2015.
• Gregory P, Jalloh M, Abe A, Hu James, Hein D. Characterization of complementary and alternative medicine-related consultations in an academic drug information service. J Pharm Pract 2015.
• Brunetti L, Hermes-DeSantis E. Patient tolerability and acceptability of colesevelam hydrochloride: focus on type 2 diabetes mellitus. P T 2015;40:1-6.
• Liu MT, Maroney ME, Hermes-DeSantis ER. Levomilnacipran and vortioxetine: review of new Pharmacotherapies for major depressive disorder. World J Pharmacol 2015;4:17-30.
• Muglia C, Kar I, Gong M, Hermes-DeSantis ER, Montelone C. Anaphylaxis to medications containing meat by-products in an alpha-gal sensitized individual. J Allergy Clin Immunol Pract 2015.
• Phillips J, Bachenheimer B. The medication safety officer’s handbook (book review). Curr Pharm Teach Learn 2015;7:560-61.
• Koppen L, Phillips J, Papageorgiou R. Analysis of reference sources used in drug-related Wikipedia articles. J Med Libr Assoc 2015;103:140-4.
• Edwards KL, Salvo MC, Ward KE, et al. Assessment and revision of clinical pharmacy practice Internet websites. Ann Pharmacotherapy 2014;48:258-67.
• Gomes DM, Ward KE, LaPlante KL. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy 2015;35:424-32.
• Landi M, Springer S, Estus E, Ward K. The impact of a student-run journal club on pharmacy students’ self-assessment of critical appraisal skills. Consult Pharm 2015;30:356-60.

Poster Presentations

• Mantovani EH, Naples JG, Rothrock-Christian T, Brown JN. Assessment of postgraduate year two pharmacy residency programs within the Veterans Affairs health care system. ASHP National Residency Preceptors Conference; Washington, DC.
• Conner B, Wood H, Brown S. Shadow a pharmacy student program at the University of Montana. Presented at: Northwest Pharmacy Convention; May 28–31, 2015; Coeur d’Alene, ID.
• Buchman CR, Brown SJ, Carter JT, Allington DR. Impact of a faculty led mock interview and residency preparation course on ASHP Match results. Presented at: Northwest Pharmacy Convention; May 28–31, 2015; Coeur d’Alene, ID.
• Wisniewski CS. Impact of a minimalistic approach to didactic PowerPoint presentations performed in a drug information course. Presented at: American Association of Colleges of Pharmacy 2015 Annual Meeting; July 11, 2015; Washington, DC.
• Tong MC, Wisniewski CS, Bosso JA. Comparison of outcomes with linezolid- and vancomycin-treated MRSA pneumonia. To be presented at: IDWeek 2015; October 10, 2015; San Diego, CA.

Other Publications

• Conrad JL. Errors related to clinical research. In: Gabay M, ed. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett, 2016.
• Conrad JL. Primary sources of information. In: Gabay M, ed. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett, 2016.
• Conrad JL, Pace HA. Introduction to clinical study design. In: Gabay M, ed. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett, 2016.
• Brunetti L, Hermes-DeSantis ER. Secondary resources. In: Gabay M. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett, 2015.
• Kar I, Gong M, Muglia C, Montelone CA, Hermes-DeSantis ER. Alpha-Gal (Mammalian meat) allergy: implications for pharmacists. Pharmacy Times. 2015 May.
• May DW, Jacquelyn Bryant. How to prepare an effective journal club. In: Gabay M. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett, 2015.
• Phillips J, Ward KE. Descriptive statistics. In: Gabay MP, ed. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett, 2015:141-52.
• Anderson G, Phillips J. Use of a technician double check system to help reduce IV compounding errors. KeePosted. 2015; March/April (online only).
• Wisiewski CS. Adverse drug reactions: detection, reporting, and prevention webinar. Presented via Internet for United Health Consortium. August 11, 2015.

New ACCP Fellows as of October 2015

• Dianne May: Augusta, GA

Other Notable Achievements

• Sherrill Brown: Chair of Library and Information Science Section of AACP

The Education and Training PRN has grown to more than 600 members who continue to advance the PRN’s mission of promoting dialogue and interaction to develop programs that enhance knowledge and skills needed to provide education and training within clinical pharmacy. The PRN is happy to share the many accomplishments of its members and looks forward to another busy year.

First, we would like to welcome Andrew Smith, Pharm.D., BCPS-AQ Cardiology, as our incoming chair-elect. Andrew is an associate clinical professor at the University of Missouri-Kansas City School of Pharmacy. We look forward to working with Andrew! Josh Caballero, Pharm.D., BCPP, will move from chair-elect to serve as chair of the PRN, and Sarah Nisly, Pharm.D., BCPS, will serve an additional year as past-chair. Laura Tsu, Pharm.D., BCPS, CGP, will continue her 2-year term as secretary/treasurer for the 2015–2016 year. We want to thank Kristi Kelley, Pharm.D., FCCP, BCPS, CDE, BC-ADM, for her leadership and commitment to the PRN as she completes her service as past-chair. Thank you, Kristi, for all of your hard work!

The EDTR PRN will once again host the mock interviews for students and residents during the 2015 Global Conference on Clinical Pharmacy immediately after the business meeting and networking forum on Monday, October 19, at 6 p.m. During the 2014 Annual Meeting, 73 interviewees, both residents and students, took part in this opportunity to learn key interviewing skills from clinical faculty and practitioners in preparation for residency or initial career position interviews. Sixty-two interviewers graciously volunteered their time to make this event a success. Most participants were able to complete at least three rounds of mock interviews to receive valuable feedback from multiple interviewers. We look forward to offering this activity at the upcoming meeting and ask that you encourage students and residents attending the meeting to take advantage of this opportunity.

The EDTR PRN will again host the third annual silent auction during the networking and business meeting. Donations from members of the PRN will be up for auction. This year, bidders will be able to peruse auction items online before the meeting and place bids. Proceeds from the auction will go to support student and resident Travel Awards. Please consider participating!

The EDTR PRN is proud of its growing membership and would like to continue to expand. We encourage ACCP members who are interested in promoting our mission to join the EDTR PRN.

The EMED PRN would like to acknowledge and congratulate all of its members on their accomplishments and achievements.

Awards

• Megan Musselman: 2015 ACCP New Clinical Practitioner Award
• Sid Patanwala: Alumni Achievement Award (Drake University, March 2015)

Publications

• Groth CM, Acquisto NM. Pharmacists as members of the rapid response team. J Pharm Pract 2014;8. [Epub]
• Kaucher KA, Acquisto NM, Rao GG, et al. Relative bioavailability of oral fosphenytoin sodium solution in healthy volunteers. Pharmacotherapy 2015;35:482-8.
• Vollman KE, Adams CB, Acquisto NM. Survey of emergency medicine education opportunities for pharmacy students and residents. Hosp Pharm 2015;50. In press.
• Awad NI. Cardiovascular risks associated with azithromycin: worth the hype? J Nurse Pract 2015;11:149-50.
• Awad NI, Brunetti L, Juurlink DN. Enhanced elimination of dabigatran through extracorporeal methods. J Med Toxicol 2015;11:85-95.
• Awad NI, Cocchio C. Assessment of hospital pharmacy preparedness for mass casualty events. P T 2015;40:264-7.
• Awad NI, Cocchio C. Use of Twitter at a major national pharmacy conference. Am J Health Syst Pharm 2015;72:65-9.
• Westrol MS, Awad NI, Bridgeman PJ, Page E, McCoy JV, Jeges J. Use of an intravascular HeatExchange catheter and intravenous lipid emulsion for hypothermic cardiac arrest after cyclobenzaprine overdose. Ther Hypothermia Temp Manag 2015. In press.
• Utkewicz MD, Brunetti L, Awad NI. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid: case report and literature review. Am J Emerg Med 2015. In press.
• Zhang Y, Kim J, Awad NI, Cocchio C. Analysis of pharmacy student perceptions and attitudes toward web 2.0 tools for educational purposes. J Pharm Technol 2015;31:127-34.
• Bailey AM, Stephan M, Weant KA, Baker Justice S. Dosing of appropriate antibiotics and time to administration of first doses in the pediatric emergency department. J Pediatr Pharmacol Ther 2015;20(4). In press.
• Cruz JE, Cocchio C, Lai PT, Hermes-DeSantis E. Gluten content of medications. Am J Health Syst Pharm 2015;71:54-60.
• Altyar A, Bakhsh HT, Mohammed A, Skrepnek G, Patanwala AE. Administration of first dose antibiotic in the ED in patients with minor skin and soft tissue infections. Am J Emerg Med 2015 May 29. [Epub ahead of print]
• Amini R, Stolz LA, Patanwala AE, Adhikari S. Coronal axis measurement of the optic nerve sheath diameter using a linear transducer. J Ultrasound Med 2015 Aug 7. [Epub ahead of print]
• Sakles JC, Mosier JM, Patanwala AE, Dicken JM, Kalin L, Javedani PP. The C-MAC® video laryngoscope is superior to the direct laryngoscope for the rescue of failed first-attempt intubations in the emergency department. J Emerg Med 2015;48:280-6.
• Thomas MC. Health maintenance/public health I. In: Bainbridge JL, Branham A, Coyle EA, et al., eds. Updates in Therapeutics®: The Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2015 ed. Lenexa, KS: American College of Clinical Pharmacy, 2015:2-673-2-705.
• Thomas MC, Shewmaker J, Musselman M. Droperidol for the treatment of acute migraine headaches. Ann Pharmacotherapy 2015;49:223-40.
• Thomas MC, Sun S. Advanced pharmacy practice experiences for pharmacy students in emergency department settings. Curr Pharm Teach Learn 2015;7:378-81.
• Macias-Moriarity LZ, Fetterman JW, Thomas MC, Stajich GV. Residency program director’s perception of PGY-1 applicants: results of the national 35 ½ second survey. Curr Pharm Teach Learn 2015;7:465-9.
• Johnson EG, Meier A, Shirakbari A, Weant K, Baker Justice S. Impact of rocuronium and succinylcholine on sedation initiation after rapid sequence intubation. J Emerg Med 2015;49:43-9.
• Schultz AE, Lewis T, Reed BS, Weant KA, Baker Justice S. That’s a phat antidote: intravenous fat emulsions and toxicological emergencies. Adv Emerg Nurs J 2015;37:1-14.
• Wilson SS, Ayaz SI, Levy PD. Relaxin: a novel agent for the treatment of acute heart failure. Pharmacotherapy 2015;35:315-27.
• O’Connor JM, Nefcy A, Wilson SS. Severe mucositis after acute substance ingestion. Clin Toxicol 2015;53:578-9.
• Raub JN. Thurston TM, Fiorvento AD, Mynatt RP, Wilson SS. Implementation and outcomes of a pharmacy residency mentorship program. Am J Health Syst Pharm 2015;72:S1-S5.

New ACCP Fellows

• Sid Patanwala
• Michael C. Thomas

Other Notable Achievements

• Sarah Barlow: Pharmacotherapy Board Certification
• Kyle Weant: Clinical Associate Professor in the Department of Clinical and Administrative Sciences at Sullivan University College of Pharmacy

The Endocrine and Metabolism PRN is composed of members from a variety of practice settings. The PRN was formed to achieve the following goals and objectives. (1) Provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas. (2) Provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem solve, and discuss professional issues and opportunities. (3) Promote practice involvement and educational needs of health care professionals, students, and patients and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort.

During the past 6 months, some notable member accomplishments are as follows.

Promotions

• Molly Minze: Associate Professor at Texas Tech University Health Sciences Center School of Pharmacy
• Ann Philbrick: Associate Professor at the University of Minnesota College of Pharmacy
• Jamie Pitlick: Associate Professor of Pharmacy Practice at St. Louis College of Pharmacy
• Krystal Riccio: Associate Professor of Pharmacy Practice at Roseman University Health Sciences
• Jonathan White: Providence Medical Group Residency Program Director-PGY2 Ambulatory Care

Research Grants

• Johnson JF. Prescribing patterns for canagliflozin (Invokana) in a specialty endocrinology group practice: patient characteristics and outcomes. Retrospective record review project in collaboration with Iowa Diabetes and Endocrinology Center and Janssen Pharmaceuticals, Health Economics and Outcomes Research Division. Funded. July 1, 2015. $30,200. Role: Principal Investigator.
• Dittman P, Kleier J, Singh-Franco D, Levin A, Colas M, Swann E, Petrosky S, Gordon AB, Hankinson M. A Community-Based, Inter-professional Diabetes Self-Management Education Project. Awarded May 2015. Nova Southeastern University, Health Professions Division Quality of Life Research Grant $10,000.

Fellowships/Honors/Awards

• Jonathan White: Oregon Society of Health-System Pharmacists – New Practitioner of the Year 2015 (presented to pharmacist in first 10 years of practice)
• Jonathan White: Providence Portland Medical Center Chairman Award – Is awarded to an individual for extraordinary contributions to the faculty team and teaching the medical residents in the Department of Medical Education

Publications

• Benitez GV, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Kimes TM, Butler MG, Karter AJ, Steiner JS, Newton K, Morales LS, Pathak RD, Thomas A, Reynolds K, Kirchner HL, Waitzfelder BE, Lafata JE, Adibhatla R, Xu Z, O’Connor PJ. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care 2015;38:905-12.
• Feigelson HS, Carroll NM, Weinmann S, Habel L, Haque R, Butler MG, Waitzfelder BE, Yu C, Wrenn MG, McGlynn EA. Treatment patterns for ductal carcinoma in-situ (DCIS) from 2000-2010 across six integrated health plans. Springer Plus. 2015;4:24. eCollection 2015.
• Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A. Asthma treatments and mental health visits after a Food and Drug Administration label change for leukotriene inhibitors. Clin Ther 2015 Apr 25. [Epub ahead of print]
• Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O’Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Elston-Lafata J, Butler MG, Kirchner HL, Ph.D., Thomas A, Steiner JF. Trends in diabetes incidence, 2006-2011, in seven million insured adults: the SUPREME-DM project. Am J Epidemiol 2015;181:32-9.
• Reynolds K, Butler MG, Kimes TM, Rosales AG, Chan W, Nichols GA. Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol 2015 May 9.
• Schroeder EB, Powers JD, O’Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, Lafata JE, Reynolds K, Thomas A, Waitzfelder BE, Steiner JF; SUPREME-DM Study Group. Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. J Diabetes Complications. 2015 Apr 16. [Epub ahead of print]
• Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;2:161-6.
• Goldman JD, Horn D. Overcoming challenges and barriers to insulin therapy in type 2 diabetes. Pharmacy Times. 2015;81:89-100. Published online May 2015. Available at www.pharmacytimes.com/Publications/issue/2015/may2015/overcoming-challenges-and-barriers-to-insulin-therapy-in-type-2-diabetes.
• Goldman JD, White J. New insulin glargine 300 U/ml for the treatment of type 1 and type 2 diabetes mellitus. Ann Pharmacotherapy 2015; published online ahead of print.
• Shaikh N, Goldman JD. Current therapy in diabetes. On the Cutting Edge (OTCE) Diabetes Care and Education – Academy of Nutrition and Dietetics 2015;36:4-7.
• Goldman-Levine JD. Combination therapy when metformin is not an option for type 2 diabetes. Ann Pharmacotherapy 2015;49:688-99.
• Johnson JF. Diabetes Case Studies (with Interprofessional Perspectives). Electronic book for instructional use as part of APhA PharmacyLibrary. Published July 2015.
• Kugler AJ, Fabbio KL, Pham DQ, Nadeau DA. Inhaled Technosphere insulin: a novel delivery system and formulation for the treatment of type 1 and type 2 diabetes mellitus. Pharmacotherapy 2015;35:298-314.
• Reece SM. Needles: the sticky details. Practical Diabetology.
• Singh-Franco D. Potential for dipeptidyl peptidase-4 inhibitor and sodium glucose cotransporter 2 inhibitor single-pill combinations. Expert Rev Endocrinol Metab 2015;10:305-17.
• Lai LL, Bleidt BA, Singh-Franco D, Elusma C, Hug G. Trends in benzodiazepine prescribing under Medicare Part D in USA: outpatient settings 2005–2009. J Pharm Health Serv Res. Article first published online: June 4, 2015.
• Winder M, Johnson J, Planas L, Crosby K, Gildon B, Oberst-Walsh L. Impact of pharmacist-led educational and error notification interventions on prescribing errors in a family medicine clinic. J Am Pharm Assoc 2015;55:238-45.

Abstracts/Poster Presentations

• Singh-Franco D, Harrington C, Tellez-Corrales E. Effect of dipeptidyl peptidase-4 inhibitors on hemoglobin a1c in patients with type 2 diabetes mellitus and renal impairment: a systematic review and meta-analysis. Value Health 2015;18:A55.
• Levin A, Singh-Franco D, Gershman J. Level of confidence and competence of immunization delivery by pharmacy interns who administer immunizations compared to pharmacy interns unable to immunize due to state law. Presented at: 2015 American Association of Colleges of Pharmacy (AACP) Annual Meeting; July 14, 2015; National Harbor, MD.

Other Notable Achievements

• Mandy Reece: Elected to the board of directors for the American Association of Diabetes Educators for the term 2016–2019
• Marquita Winder: Certified Diabetes Educator

Introduction

Please join us at the 2015 ACCP Global Conference on Clinical Pharmacy in San Francisco, California, from October 17 to 21, 2015!

The GILN PRN will host its annual business meeting and networking forum on Monday, October 19, 2015, 6:00 p.m. – 9:00 p.m. This meeting is open to current and prospective members. Appetizers and beverages will be provided.

During the meeting, the GILN PRN will present its focus session on Pharmacotherapy Advances and Nutrition in the Management of Patients with IBD and IBS from 1:30 p.m. to 3:00 p.m. on Tuesday, October 20, 2015.

Publications

• Toussaint-Miller K, Andres J. A special touch: treatment considerations for unique patient populations with HCV genotype 1 infection. Ann Pharmacotherapy.
• Bounda GA, Yu F. Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds. Pharmacognosy Res 2015;7:225-36.
• Bounda GA, Zhou W, Wang D, Yu F. Rhein elicits in vitro cytotoxicity in primary human liver HL-7702 cells by inducing apoptosis via mitochondria-mediated pathway [abstract]. Pharmacotherapy 2015;35:e70-e71.
• Bounda GA, Zhou W, Wang D, Yu F. Rhein elicits in vitro cytotoxicity in primary human liver HL-7702 cells by inducing apoptosis via mitochondria-mediated pathway. Evid Based Complement Altern Med 2015, Article ID: 329831.
• Bechard LJ, Gordon C, Feldman HA, Venick R, Gura K, Guinan EC, Duggan C. Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation. Pediatr Blood Cancer 2015;62:687-92.
• Hemstreet B. Inflammatory bowel disease. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program, 2015 Book 2. Women’s and Men’s Care. Lenexa, KS: American College of Clinical Pharmacy, 2015:231-48.
• Hemstreet B. Vitamin D’s role in the pathogenesis and treatment of IBD. Pharmacy Today. August 2015;21(8). Available at www.pharmacist.com/vitamin-d-s-role-pathogenesis-and-treatment-ibd.
• Kale-Pradhan PB, Mihaescu A, Wilhelm SM. Fluoroquinolone sequential therapy for Helicobacter pylori: a meta-analysis. Pharmacotherapy 2015 Jul 15. [Epub ahead of print]
• Seifert CF, Brown AT. IDSA or ACG guidelines for treatment for Clostridium difficile infection: which one to follow? [author’s reply]. Am J Med 2015:128:e19.
• Seifert CF, Brown AT. Proton pump inhibition may promote Clostridium difficile recurrences [author’s reply]. Am J Med 2015;128:e15.
• Smith A. Chapter 14: gastrointestinal system. In: Patient Assessment in Pharmacy Practice, 3rd ed. Philadelphia: Wolters Kluwer, 2016:255-75.
• Smith A. Chapter 15: hepatic system. In: Patient Assessment in Pharmacy Practice, 3rd ed. Philadelphia: Wolters Kluwer, 2016:276-92.
• Smith MA, Benedict NJ. Effectiveness of educational technology to improve patient care in pharmacy curricula. Am J Pharm Educ 2015;79:Article 15.
• Smith MA, Chan J, Mohammad RA. Ledipasvir-sofosbuvir: interferon/ribavirin-free regimen for chronic hepatitis C virus infection. Ann Pharmacotherapy 2015;49:343-50.

Presentations

• Hemstreet B. Gastrointestinal disorders. American College of Clinical Pharmacy Updates in Therapeutics®: Pharmacotherapy Preparatory Course; April 2015; Chicago, IL.
• Hemstreet B. Navigating the P4 year. American College of Clinical Pharmacy Emerge from the Crowd: How to Become a Standout Residency Candidate Program; April 2015; Chicago, IL.
• Hemstreet B. Endocrine disorders. American College of Clinical Pharmacy 2015 Clinical Pharmacy Summit; March 2015; Manila, Philippines.
• Hemstreet B. Pulmonary disorders. American College of Clinical Pharmacy 2015 Clinical Pharmacy Summit; March 2015; Manila, Philippines.
• Hemstreet B. Applying clinical skills for effective practice: Pre-conference Career Advancement Symposium: Developing the Competencies of an Effective Clinical Practitioner and Teacher. 15th Asian Conference on Clinical Pharmacy; June 2015; Bangkok, Thailand.
• Hemstreet B. The attributes of an effective clinician: Pre-conference Career Advancement Symposium: Developing the Competencies of an Effective Clinical Practitioner and Teacher. 15th Asian Conference on Clinical Pharmacy; June 2015; Bangkok, Thailand.
• Hemstreet B. Pharmacotherapy and Clinical Practice Workshop; King Saud Medical City; May 2015; Riyadh, Kingdom of Saudi Arabia.
• Martin MT. Top things to know about hepatitis C virus now. Illinois Council on Health-System Pharmacists (ICHP) Annual Meeting; September 11, 2015; Oakbrook Terrace, IL.
• Smith AN. Pharmacological treatment of obesity. American Society for Metabolic and Bariatric Surgery (ASMBS) Weekend Meeting; June 2015; Las Vegas, NV.
• Smith AN. Perioperative pharmacology in the bariatric surgery patient: who, what, where, why all the prep? American Society for Metabolic and Bariatric Surgery (ASMBS) Weekend Meeting; June 2015; Las Vegas, NV.
• Crabtree BL, Salinitri FD, Wilhelm SM, Riche DM. Training faculty and clinicians for small group facilitation. AACP & AFPC Annual Meeting; July 2015; National Harbor, MD.

Other Notable Achievements

• Guy-Armel Bounda received his Ph.D. degree in clinical pharmacy, China Pharmaceutical University, in June 2015. His thesis was titled “Herbal Medicines and Liver Damage: Mechanism of HepatotoxicityIinduced by Rhein; a Polygonum multiflorum Bioactive Component.”
• Brian Hemstreet: Elected to the ACCP Board of Regents. His 3-year term starts in October 2015.

Promotions

• Antoine Jenkins: Clinical Associate Professor – Chicago State University – College of Pharmacy
• Jeannie K. Lee: Associate Professor – University of Arizona – College of Pharmacy
• Rebecca Sleeper: Professor – TTUHSC School of Pharmacy

Awards

• Jeannie Lee: Arizona Geriatric Education Center Certificate for Outstanding Contribution
• Emily Peron: Teacher of the Year Nominee, VCU School of Pharmacy, May 2015
• Emily Peron: Inducted as a faculty member of Phi Lambda Sigma Leadership Society, VCU School of Pharmacy, March 2015
• Barbara J. Zarowitz: 2015 Selection for the George M. Archambault Award

Grants

• “Caregiver Type and Knowledge of Medication Management for Geriatric Patients: A Prospective Study” – University of Houston New Faculty Research Program Grant (Julianna Fernadez)
• Sue Fosnight. Geriatrics Workforce Enhancement Program. Department of Health and Human Services Agency for Health Care Research and Quality. July 1, 2015 – June 30, 2018. Coinvestigator
• Sue Fosnight. Nurse Education, Practice, Quality, and Retention-Interprofessional Collaborative Practice. Department of Health and Human Services Agency for Health Care Research and Quality. July 1, 2015 – June 30, 2018. Coinvestigator
• Jeannie Lee: Arizona Geriatric Workforce Enhancement Program (AZ-GWEP) Source: HRSA (UIQHP28721). Goal: To develop a capable, diverse, and culturally competent Arizona health professions workforce focused on ensuring Arizona’s elders’ improved health outcomes including function and quality of life. Role: Coinvestigator (PI, Mindy Fain and Jane Mohler, Arizona Center on Aging). Amount: $2,500,000 % Effort: 10%
• Zachary A. Marcum. Northwest Geriatric Workforce Enhancement Center (HRSA-15-057) (Vitiello/Phelan PI) – HRSA. July 1, 2015 – June 30, 2018. Role: Center Steering Committee
• Zachary A. Marcum. R34HL123500-01A1 (Morone/McTigue PI) – NHLBI. Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control. May 15, 2015 – March 31, 2018. Role: Coinvestigator
• Magnet M, Shibley J, Kaefer T, Peron EP, Larson T, Helmke J. Bremo Transitions of Care Program (BremoTOC): BremoBedside Medication Delivery and BremoTransitions; February 11, 2015 – February 11, 2017. Virginia Pharmacists Association Foundation Incentive Grants Program: $2480
• “Identification of Pseudobulbar Affect Symptomatology in the Nursing Facility: Pilot of a Screening Tool,” Avanir Pharmaceuticals, Barbara Zarowitz (Principal Inv.), Terry O’Shea, Carrie Allen. $161,500 1/14/2015 – present
• “Characteristics and Outcomes of Opioid-Treated Residents with Constipation in the Nursing Home,” AstraZeneca Pharmaceuticals, LP, Barbara Zarowitz (Principal Inv.), Terry O’Shea, Carrie Allen $193,600 3/2/2015 – present
• “Demographic and Clinical Characteristics of Residents with a Diagnosis of Seizure Disorder or Epilepsy in the Nursing Home Setting,” Eisai, Barbara Zarowitz (Principal Inv.), Terry O’Shea, Carrie Allen, $129,450; 4/14/2015 – present

Publications

• Blaszczyk AT, Sleeper RB, Bailey TA, Duncan NM, McCarrel J, Clifford KM. Workarounds during the transcription of medication orders in the long-term care setting. Ann Longterm Care 2015;23:33-7.
• Benitez GV, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Kimes TM, Butler MG, Karter AJ, Steiner JS, Newton K, Morales LS, Pathak RD, Thomas A, Reynolds K, Kirchner HL, Waitzfelder BE, Lafata JE, Adibhatla R, Xu Z, O’Connor PJ. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care 2015;38:905-12.
• Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A. Asthma treatments and mental health visits after a Food and Drug Administration label change for leukotriene inhibitors. Clin Ther 2015;37:1280-91.
• Reynolds K, Butler MG, Kimes TM, Rosales AG, Chan W, Nichols GA. Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol 2015;116:400-5.
• Schroeder EB, Powers JD, O’Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, Lafata JE, Reynolds K, Thomas A, Waitzfelder BE, Steiner JF; SUPREME-DM Study Group. Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. J Diabetes Complications. 2015;29:637-43.
• Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;2:161-6.
• Essex MN, O’Connell MA, Behar R, Bao W. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study. Int J Rheum Dis 2015 May 20. [Epub ahead of print]
• Wilford R, Fosnight S, Allen K. 3D-cam [letter to the editor]. Ann Intern Med 2015;162:527.
• Co-editor: Lisa C. Hutchinson, Rebecca B. Sleeper: Fundamentals of Geriatric Pharmacotherapy, 2nd ed. Bethesda, MD: ASHP, 2015.
• Gritsenko D, Hughes GJ. Ledipasvir/sofosbuvir (Harvoni): improving options for hepatitis C virus infection. P T 2015;40:256-76.
• Tran TH, Hughes GJ, Greenfeld C, Pham JT. Overview of current and alternative therapies for idiopathic membranous nephropathy. Pharmacotherapy 2015;35:396-411.
• Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF. Regional variation in use of a new class of antidiabetic medication among Medicare beneficiaries: the case of incretin mimetics. Ann Pharmacotherapy 2015;49:285-92.
• Marcum ZA, Gurwitz JH, Colón-Emeric C, Hanlon JT. Pills and ills: methodologic issues in pharmacologic research. J Am Geriatr Soc 2015;63:829-30.
• Marcum ZA, Hardy S. Medication management skills in older skilled nursing facility residents transitioning home. J Am Geriatr Soc 2015;63:1266-8.
• Marcum ZA, Kisak A, Visoiu, Resnick N. Medication discrepancies and shared decision making. J Am Geriatr Soc 2015. In press.
• Marcum ZA, Kisak A, Visoiu, Resnick N. Medication reconciliation: will the real medication list please stand up? J Am Geriatr Soc 2015. In press.
• Marcum ZA, Perera S, Newman AB, Thorpe JM, Switzer GE, Gray SL, Simonsick EM, Shorr RI, Bauer DC, Castle NG, Studenski SA, Hanlon JT. Antihypertensive use and recurrent falls in community-dwelling older adults: findings from the Health ABC study. J Gerontol A Biol Sci Med Sci 2015. In press.
• Marcum ZA, Perera S, Thorpe JM, Switzer GE, Gray SL, Castle NG, Strotmeyer ES, Simonsick EM, Bauer DC, Shorr RI, Studenski SA, Hanlon JT. Anticholinergic use and recurrent falls in community dwelling older adults: findings from the Health ABC study. Ann Pharmacotherapy 2015. In press.
• Culley CM, Perera S, Marcum ZA, Kane-Gill SL, Handler SM. Using a clinical surveillance system to detect drug-associated hypoglycemia in nursing home residents. J Am Geriatr Soc 2015. In press.
• Felton MA, Hanlon JT, Perera S, Thorpe JM, Marcum ZA. Racial differences in anticholinergic use among community-dwelling elders. Consult Pharm 2015;30:240-5.
• Lo-Ciganic WH, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF. Using machine learning to examine medication adherence thresholds and risk of hospitalization. Med Care 2015;53:720-8.
• Naples JG, Marcum ZA, Perera S, Gray SL, Newman AB, Simonsick EM, Yaffe K, Shorr RI, Hanlon JT. Concordance among anticholinergic burden scales. J Am Geriatr Soc 2015. In press.
• Radomski TR, Good CB, Thorpe CT, Zhao X, Marcum ZA, Glassman PA, Lowe J, Mor M, Fine MJ, Gellad WF. Variation in formulary management practices within the VA healthcare system. J Manag Care Specialty Pharm 2015. In press.
• Weiner DK, Fang M, Gentili A, Kochersberger G, Marcum ZA, Rossi MI, Semla TP, Shega J. Deconstructing chronic low back pain in the older adult—step by step evidence and expert-based recommendations for evaluation and treatment. Part I: hip osteoarthritis. Pain Med 2015;16:886-97.
• Cao Q, Lee T, Hayes S, Nye AM, Hamrick I, Shivajiro P, Steinweg K. Are geriatric medicine fellows prepared for the important skills of hospice and palliative care? Am J Hosp Palliat Care 2015;32:322-8.
• Fabo K, Nye AM, Gagliardi J, Nye AM, Dennis C, Muzyk A. Evaluation of changes in citalopram prescribing patterns following a US Food and Drug Administration Alert: a retrospective cohort study. Prim Care Companion CNS Disord 2015;17(1).
• Hamrick I, Schrager S, Nye AM. Treatment of osteoporosis: current state of the art. Wien Med Wochenschr 2015;165:54-64.
• Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Clin Geriatr Med 2015;31:17-27.
• Hobgood S, Peron EP, Collison E, Shamaskin-Garroway A, Sicat B, Bishop S. Interprofessional Team-Based Learning Module: Dementia, Depression, and Delirium. MedEdPORTAL Publications, 2015. Available at https://www.mededportal.org/publication/10033.
• Aspinall SL, Zhao X, Semla TP, Cunningham FE, Paquin AM, Pugh MJ, Schmader KE, Stone RA, Hanlon JT; the Veterans Affairs Community Living Center Pharmacotherapy Research Group. Epidemiology of drug-disease interactions in older Veteran nursing home residents. J Am Geriatr Soc 2015;63:77-84.
• Sakely H, Corbo J, Coley M, Thorpe C, Klatt P, Schleiden L, Zaharoff J, Cox-Vance L, Balestrino V, McGivney MS. Pharmacist-led collaborative practice for older adults. Am J Health Syst Pharm 2015;72:606-9.
• Salvig BE, Easterling JL, Moseley MV, Patel EL, Joppich MH, Bean JR. Improving antipsychotic use in a Veterans Affairs community living center. Ann Longterm Care 2015;23:35-9.
• Zarowitz B, Allen C, O’Shea T, Dalal M, Haumschild M, DiGenio A. Type 2 diabetes mellitus treatment patterns in US nursing home residents. Postgrad Med 2015; Early Online April 8; 1-9.
• Zarowitz B, Cheung LI, Allen C, O’Shea T, Stolshek B. Prevalence and clinical characteristics of treated and untreated osteoporosis in nursing home residents. JAMDA 2015;16:341-8.
• Zarowitz B, O’Shea T, Allen C, Tangalos E, Ouslander J, Berner T. Clinical burden and non-pharmacologic management of nursing home residents with urinary incontinence and/or overactive bladder. Consult Pharm 2015. Accepted for publication.
• Zarowitz B, O’Shea T, Allen C, Tangalos E, Ouslander J, Berner T. Challenges in the pharmacologic management of nursing home residents with urinary incontinence and/or overactive bladder. J Am Geriatr Soc 2015. Accepted for publication.
• Zarowitz BJ, Allen C, O’Shea T, Strauss M. Risk factors, clinical characteristics and treatment differences between residents with and without nursing home and non-nursing-acquired Clostridium difficile infection. JMCP 2015;21:585-95.
• Vouri SM, Crist SM, Sutcliffe S, Austin S. Changes in mood in new enrollees at a program of all-inclusive care for the elderly (PACE). Consult Pharm 2015;30:463-71.

Abstracts/Posters/Presentations

• Blaszczyk A, Estus E, Boumeester C, Emptage R, Lee J, Mahan R, Slattum P, Vouri S, Brodeur M, Niehoff K. Developing a geriatric pharmacy curriculum guide, 3rd ed. J Am Geriatr Soc 2015;63:S194-S195.
• Essex MN, Hopps M, Udall M, Fu C, Bienen EJ, Mardekian J, Makinson G. Relationship of serum uric acid levels with hypertension and hyperlipidemia in patients with gout. Internal Society for Pharmacoeconomics and Outcomes Research 20th Annual International Meeting; May 16–20, 2015; Philadelphia, PA.
• Essex MN, Hopps M, Udall M, Fu C, Bienen EJ, Mardekian J, Makinson G. Relationship of serum uric acid levels with cardiovascular disease in patients with gout: a retrospective analysis of electronic health records data. EULAR 2015; June 10–13, 2015; Rome, Italy.
• Essex MN, Hopps M, Udall M, Fu C, Bienen EJ, Mardekian J, Makinson G. Does high serum uric acid increase the risk of renal disease in patients with gout? Results from a retrospective analysis of electronic health records data. EULAR 2015; June 10–13, 2015; Rome, Italy.
• Rüdell K, Bobula J, Fu C, Mardekian J, Sadosky A, Essex MN, Taylor W. Comparing burden of illness of tophaceous with non-tophaceous gout patients using a large US electronic health records database. Internal Society for Pharmacoeconomics and Outcomes Research 20th Annual International Meeting, May 16-20, 2015, Philadelphia, PA.
• Sakely H. The impact of pharmacists caring for geriatric patients across the healthcare continuum on the identification, resolution, and prevention of drug therapy problems: a subset of the PIVOTS (Pharmacist-led Interventions on the Transitions of Seniors) Group. American Geriatrics Society Annual Meeting – 1st place awardee for Resident and Fellow Abstract, Models of Care Category.
• Breslin T, Durigan R, Payette N, Bacci J, Klatt P, McGivney M, Corbo J, Coley K, Thorpe C, Cox-Vance L, Zaharoff J, Sakely H. Physician perceptions of pharmacists integrated within their practice: a mixed methods analysis of effects on patient care and non-patient care activities. American Geriatrics Society Annual Meeting – 2nd place awardee for Resident and Fellow Abstract, Models of Care Category.
• Campbell A, Coley K, Thorpe C, Corbo J, McGivney M, Klatt P, Zaharoff J, Cox-Vance L, Higbea AM, Thorpe C, Cox-Vance L, McGivney M, Coley K, Schleiden L, Zaharoff J, Corbo J, Klatt P, Sakely H. Improving care of older adults within a novel practice: patient perceptions and self-efficacy analysis of Pharmacist-led Interventions on Transitions of Seniors (PIVOTS) by patient surveys. American Geriatrics Society Annual Meeting – 3rd place awardee for Resident and Fellow Abstract, Models of Care Category.
• Payette N, Breslin T, Durigan R, Klatt P, Bacci J, Coley K, McGivney M, Corbo J, Cox-Vance L, Driessen J, Thorpe C, Zaharoff J, Sakely H. Time-in motion analysis of the geriatric clinical pharmacist in four geriatric care settings: Pharmacist-led Interventions on Transitions of Seniors (PIVOTS). American Geriatrics Society Annual Meeting.

Other Notable Achievements

• Nicolette Centanni: Certification in Geriatric Pharmacy
• Christine Eisenhower: “Pharmacist-Initiated Optimization of Inhalers in High-Risk, Older Adults with COPD” – ACCP MeRIT Scholar
• Scott Vouri: MSCI degree from Washington University in St. Louis

Introduction

The Global Health PRN is celebrating its first year in residence with ACCP. We are now more than 130 members strong and growing. The 2015 PRN election slate showcased highly qualified members, and we are proud to welcome Michelle Holm as chair-elect and Kristin Darin as secretary/treasurer. Renee Holder will return as chair.

Through the efforts of the Programming Task Force, both joint PRN focus sessions submitted for presentation at the Global Conference on Clinical Pharmacy were accepted. In addition, the Scholarship Task Force submitted a poster describing the creation of the PRN that has been accepted. Please check the meeting schedule so that you don’t miss these sessions. See you in San Francisco!

Promotions

• Katie Carls: Clinical Manager of International Content for Lexicomp at Wolters Kluwer
• Kevin O. Rynn: Vice Dean, Rosalind Franklin University of Medicine and Science College of Pharmacy

Awards

• Sally Arif: Class of 2017 Teacher of the Year, Midwestern University Chicago College of Pharmacy
• Susan Raber: Health Volunteers Overseas (HVO) Golden Apple Award (strong commitment to HVO’s mission to improve global health through education, training, and professional development of the health workforce in resource-scarce countries)

Grants

• Cory Nelson: 2015 Cardinal Health E3 Grant, $45,000
• Sonak Pastakia: NIH R01 Bridging Income Generation Through Group Integrated Care – Coinvestigator
• Sonak Pastakia: Medical Research Council UK – “Ethnic Specific Risk Stratification in Early Pregnancy for Identifying Mothers at Risk of Gestational Diabetes Mellitus in Kenya and India” – Co-PI
• Sonak Pastakia: Celgene – Pharmacy Infrastructure Development Grant – PI
• Sonak Pastakia: Abbott – Addressing diabetes care needs through rural western Kenya–Co-I
• Emily Peron: Improving School Meals Program; 06/01/2015-06/01/2016. VCU Global Education Office Global Health Funds: $1800.

Publications

• Pastakia SD, Cheng SY, Kirui, et al. Dynamics, impact, and feasibility of self-monitoring of blood glucose in the rural, resource-constrained setting of Western Kenya. Clin Diabetes 2015.
• Pastakia SD, Njuguna B, Le P, Brock TB. To address emerging infections, we must invest in enduring systems: the kinetics and dynamics of health systems strengthening. Clin Pharmacol Ther 2015.
• Bhavadharini B, Mohanraj M, Pastakia SD, et al. Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings. Acta Diabetol 2015.
• Crowe S, Manyara S, Pastakia SD. Lessons still needing to be learned. Curr Pharm Teach Learn 2015;7:141-3.
• Park PH, Wambui CK, Pastakia SD, et al. Improving diabetes management and cardiovascular risk factors through peer-led self-management support groups in western Kenya. Diabetes Care 2015;38:e110-e111.
• Shirey K, Manyara S, Pastakia SD (corresponding author), et al. Symptoms of depression among patients attending a diabetes care clinic in rural western Kenya. J Clin Transl Endocrinol 2015;2:51-4.

New ACCP Fellow

• Katherine Smith: South Jordan, UT

Other Notable Achievements

• Sonak Pastakia: Our Counterfeit Detection program was featured on BBC a few months ago. The story site has a link to the video clip toward the bottom, which they aired on TV: www.bbc.com/news/health-32938075.

Grants

• Baker WL (PI): “Magnesium for Treatment of Atrial Fibrillation”: Connecticut Institute for Clinical and Translational Science (CICATS) Pre-K Scholar Program
• Baker WL (PI): “Oral Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis.” Pfizer.

Publications

• Baker WL, Coleman CI. Medication adherence and non-vitamin K antagonist oral anticoagulants: what do we really know? Europace. In press.
• Baker WL, Kluger J, Coleman CI, White CM. Impact of magnesium L-lactate on occurrence of ventricular arrhythmias in patients with implantable cardioverter defibrillators: a randomized, placebo-controlled trial. Open Cardiovasc Med J 2015. In press.
• Baker WL, Radojevik J, Gluck JA. Systematic review of phosphodiesterase-5 inhibitors for preventing right ventricular failure following left ventricular assist device implantation. Artif Organs 2015. In press.
• Chamberlin KW, Baker WL. Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients. Clin Interv Aging 2015;10:733-40.
• Benitez GV, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Kimes TM, Butler MG, Karter AJ, Steiner JS, Newton K, Morales LS, Pathak RD, Thomas A, Reynolds K, Kirchner HL, Waitzfelder BE, Lafata JE, Adibhatla R, Xu Z, O’Connor PJ. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, lipids and active smoking in adults with diabetes with and without cardiovascular disease: A contemporary analysis. Diabetes Care 2015;38:905-12.
• Feigelson HS, Carroll NM, Weinmann S, Habel L, Haque R, Butler MG, Waitzfelder BE, Yu C, Wrenn MG, McGlynn EA. Treatment patterns for ductal carcinoma in-situ (DCIS) from 2000-2010 across six integrated health plans. Springer Plus. 2015;4:24. eCollection 2015.
• Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A. Asthma treatments and mental health visits after a Food and Drug Administration label change for leukotriene inhibitors. Clin Ther 2015 Apr 25. [Epub ahead of print]
• Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O’Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Elston-Lafata J, Butler MG, Kirchner HL, Ph.D., Thomas A, Steiner JF. Trends in diabetes incidence, 2006-2011, in seven million insured adults: the SUPREME-DM project. Am J Epidemiol 2015;181:32-9.
• Reynolds K, Butler MG, Kimes TM, Rosales AG, Chan W, Nichols GA. Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol 2015 May 9.
• Schroeder EB, Powers JD, O’Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, Lafata JE, Reynolds K, Thomas A, Waitzfelder BE, Steiner JF; SUPREME-DM Study Group. Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. J Diabetes Complications. 2015 Apr 16. [Epub ahead of print]
• Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;2:161-6.
• Olson KL, Stiefl M, Ross C, Stadler S, Hornak R, Sandhoff B, Merenich JA. Self-rated health among patients with coronary artery disease enrolled in a cardiovascular risk reduction service. Popul Health Manage August 3, 2015. In press.
• Adams J, Cymbala AC, Delate T, Kurz D, Olson KL, Youngblood M, Zadvorny E. Cluster randomized trial of clinical pharmacist tobacco cessation counseling among patients with cardiovascular disease. Popul Health Manage 2015;18:300-6.
• Delate T, Rader N, Rawlings J, Smith K, Herner S. Clinical outcomes of continuation of metformin titration instructions with electronic prescribing. Drugs Real World Outcomes April 2015.
• Sarker A, Ginn R, Nikfarjam A, O’Connor K, Smith K, Jayaraman S, Upadhaya T, Gonzalez G. Utilizing social media data for pharmacovigilance: a review. J Biomed Inform 2015;54:202-12.
• Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: a network meta-analysis. Thromb Res 2015;888-96.
• Hom L, Sobieraj DM. The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patient admitted to the hospital for venous thromboembolism. Int J Cardiol 2015;198:87-8.
• Hurley C, Dai S, Sobieraj DM. The impact of rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation. Int J Cardiol 2015;192:1-2. [Epub ahead of print]
• Linder KE, Sobieraj DM. MTM essentials for asthma management: part 1. Drug Top April 2015.
• Mearns E, Sobieraj DM, White CM, Saulsberry WJ, Kohn CG, Doleh Y, Zaccaro E, Coleman CI. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis. PLoS One 2015;10:e0125879.
• Nigro SC, Sobieraj DM. MTM essentials for asthma management: part 2. Drug Top May 2015.

Promotions

• Yvonne Mai: From Pharmacy Fellow in Pharmacoeconomics and Health Outcomes to Assistant Professor of Pharmacy Practice and APPE Regional Coordinator at University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences
• Karen Smith: Associate Professor, Pharmacy Practice, Regis University School of Pharmacy
• Snyder ME: Associate Professor of Pharmacy Practice (with Tenure), Purdue University College of Pharmacy

Other Achievements

• Yvonne Mai: Research titled “Frequency and Severity of Medication-Related Problems Identified in Community-Dwelling Medicare Beneficiaries: Three Year Analyses of Mobile Clinic Data” was selected for podium presentation at American Public Health Association Conference 2015 in Chicago

Introduction

The Hematology/Oncology PRN continues to provide a forum for hematology/oncology pharmacists to network and collaborate on scientific, educational, and political issues affecting clinical practice, teaching, and research. We have grown to 968 members, a significant portion of whom are trainees (402 students; 69 residents/fellows).

Because student interest has continued to grow steadily each year, the Trainee Committee is currently working on expanding mentoring and networking opportunities. One of these initiatives is a new networking session that will be part of the PRN business meeting at the ACCP 2015 Global Conference on Clinical Pharmacy.

Several other PRN committee efforts are well under way. The 2015 Hematology/Oncology PRN focus session was approved, and the Focus Session Committee will develop a session titled “Confronting the Global Epidemic of HPV and Associated Malignancies.” The discussions on the prevention and treatment of HPV-related cancers will be led by three renowned guest speakers: Joel Palefsky, M.D. (Professor of Medicine) from the Department of Infectious Diseases at the USCF School of Medicine; Judith Smith, Pharm.D., FCCP, FISOPP, BCOP, CPHQ (Associate Professor) from the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Texas Medical School; and Sarah Scarpace, Pharm.D., MPH, BCOP (Associate Professor) from the Department of Pharmacy Practice at Albany College of Pharmacy.

The Hematology/Oncology PRN Paper Committee has completed and submitted a manuscript to Pharmacotherapy that evaluates the current types of clinical practices being used by hematology/oncology pharmacists in our PRN in an effort to contribute to the literature documenting pharmacist involvement in the care of patients with cancer.

Promotions

• John Bossaer: Associate Professor in the Department of Pharmacy Practice at the Bill Gatton College of Pharmacy, East Tennessee State University
• LeAnn B. Norris: Associate Professor in the Department of Clinical Pharmacy and Outcomes Sciences at the South Carolina College of Pharmacy, University of South Carolina Campus

Grants

• Becky Fahrenbruch: American Society of Health-System Pharmacists (ASHP) Research and Education Foundation Pharmacy Residency Expansion Grant for the PGY2 Oncology Residency at the University of Minnesota
• Ninh (Irene) La-Beck: Awarded a $453,173 NIH R15 grant from the National Cancer Institute titled “Abrogating Nanoparticle-Induced Immunosuppression in Tumor Microenvironment.” This project aims to understand mechanisms by which nanoparticle carriers diminish antitumor immunity and to develop strategies to abrogate these effects using modified nanoparticles. This work will be carried out primarily in the Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center School of Pharmacy.
• Christine Walko: Coinvestigator (PK) on a recently awarded $1,500,000 grant from the Kay Yow Cancer Fund/V Foundation titled “Personalizing the Care of Older Women with Ovarian Cancer” (Extermann M, Principal Investigator; May 2015 – April 2016)

Awards

• Saeed Alzghari: TEVA Outstanding Student Award (TEVA Pharmaceuticals USA, Inc.) and the Glenda Lawson McRee Pharmacy Student Award (Texas Society of Health-System Pharmacists)
• Alexandre Chan: Multinational Association of Supportive Care in Cancer (MASCC) 2015 Steven M. Grunberg Memorial Award in recognition of scientific excellence, leadership and mentoring in the field of supportive care in cancer
• Dave Henry: Hematology/Oncology Pharmacy Association (HOPA) Award of Excellence 2015
• Lucas Okumura: Best Paper Award in the Student/Resident/Fellow category at the American College of Clinical Pharmacy 2015 Virtual Symposium. The research poster presented was as follows: Okumura L, Riveros B, da Silva M, Veroneze I. Cost-effectiveness of different strategies of antimicrobial stewardship programs.
• Shoshanna Robinson: Concord Pharmacy Scholarship and Dean’s List Scholarship recipient

Publications

• Bossaer JB. Addressing potential interactions between antineoplastics and dietary supplements. Am J Health Syst Pharm 2015;72:915-6.
• Bossaer JB, Chakraborty K. Drug interaction between idelalisib and diazepam resulting in altered mental status and respiratory failure. J Oncol Pharm Pract. Accepted for publication.
• Bossaer JB, Panus PC, Stewart DW, Hagemeier N. Student performance in a Pharmacotherapy oncology module before and after flipping the classroom. Am J Pharm Ed. Accepted for publication.
• Cheung YT, Ng T, Shwe M, Ho HK, Foo KM, Cham MT, Lee JA, Fan G, Tan YP, Yong WS, Madhukumar P, Loo SK, Ang SF, Wong M, Chay WY, Ooi WS, Dent RA, Yap YS, Ng R, Chan A. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol 2015;26:1446-51.
• Cheung YT, Ong YY, Ng T, Tan YP, Fan G, Chan CW, Molassiotis A, Chan A. Assessment of mental health literacy in patients with breast cancer. J Oncol Pharm Pract 2015 Jun 4. [Epub ahead of print]
• Langbecker D, Ekberg S, Yates P, Chan A, Chan RJ. What are the barriers of quality survivorship care for haematology cancer patients? Qualitative insights from cancer nurses. J Cancer Surviv. 2015 May 30. [Epub ahead of print]
• Holle LM, Puri S, Clement JM. Physician–pharmacist collaboration for oral chemotherapy monitoring: insights from an academic genitourinary oncology practice. J Oncol Pharm Pract 2015. [Epub ahead of print]
• Mar N, Holle L, Wasser JS, Hook K. Hepatitis screening and management before rituximab administration. J Clin Oncol. 2015;33 (suppl; abstr e17747).
• Pherwani N, Ghayad JM, Holle LM, Karpiuk E. Outpatient treatment of febrile neutropenia in cancer patients: risk stratification and treatment review. Am J. Health Syst Pharm 2015;72:619-31.
• La-Beck NM, Jean GW, Huynh C, Alzghari SK, Lowe DB. Immune checkpoint inhibitors: new insights and current place in cancer therapy. Pharmacotherapy. Accepted for publication.
• Gabizon AA and La-Beck NM. Optimizing nanoparticle delivery of chemotherapeutics. In: Cancer Nanotechnology Plan 2015. National Cancer Institute. [Available Fall 2015, www.nano.cancer.gov]
• Golan T, Grenader T, Ohana P, Amitay Y, Shmeeda H, La-Beck NM, Tahover E, Berger R, Gabizon AA. Pegylated liposomal mitomycin-C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. Cancer Med 2015 Jul 14. [Epub ahead of print]
• Rajan R, Sabnani M, Karbowniczek M, Astrinidis A, La-Beck NM. Quantifying autophagosomes and autolysosomes in cells using imaging flow cytometry. Cytometry A 2015;87:451-8.
• Chhatwal J, Mathisen M, Kantarjian H. Are high drug prices for hematologic malignancies justified? A critical analysis. Cancer 2015 June 23. [Epub ahead of print]
• Kantarjian H, Mathisen MS, Lipton JH. Having skin in the game and allowing cross-border importation of drugs to lower high prices of cancer drugs. JAMA Oncol 2015 July 2. [Epub ahead of print]
• Wang E, Farmakiotis D, Yang D, McCue DA, Kantarjian HM, Kontoyiannis DP, Mathisen MS. The ever-evolving landscape of candidaemia in patients with acute leukemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J Antimicrob Chemotherapy 2015;70:2362-8.
• Norris LB. Benign prostatic hyperplasia and prostate cancer. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program, 2015 Book 2. Women’s and Men’s Care. Lenexa, KS: American College of Clinical Pharmacy, 2015:163-84.
• Okumura LM, Antunes VDC, Aguiar KS, Farias TF, Andrzjeveski VMS, Funke VM. Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment. Pharmacy Practice (Granada. Internet) 2015;13:1-7.
• Pherwani N, Ghayad JM, Holle LM, Karpiuk EL. Outpatient management of febrile neutropenia associated with cancer Chemotherapyapy: risk stratification and treatment review. Am J Health Syst Pharm 2015;72:619-31.
• Saunders IM, Lahoti A, Chemaly RF, et al. Topical cidofovir–induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract 2014;0:1-7.
• Saliba RM, Rezvani K, Leen A, … Saunders IM, Bollard CM, Shpall EJ. General and virus-specific immune cell reconstitution following double cord blood transplantation. Biol Blood Marrow Transplant 2015;21:1284-90.
• Do T, Niravath P, Trivedi MV. The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis. Breast Cancer Res Treat. Accepted.
• Giuliano M, Herrera S, Christiny P, Shaw C, Creighton CJ, Mitchell T, Bhat R, Zhang X, Mao S, Dobrolecki LE, Al-rawi A, Chen F, Veneziani BM, Zhang XH, Hilsenbeck SG, Contreras A, Gutierrez C, Jeselsohn RM, Rimawi MF, Osborne CK, Lewis MT, Schiff R, Trivedi MV. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. Breast Cancer Res 2015;17:3.
• Giuliano M, Wang YC, Gutierrez C, Rimawi MF, Chang JC, Wang T, Hilsenbeck SG, Trivedi MV, Chamness GC, Osborne CK, Schiff R. Upregulation of estrogen receptor signaling in HER2-positive breast cancer patients treated with neoadjuvant lapatinib: a translational study. Clin Cancer Res. In press.
• Nardone A, De Angelis C, Trivedi MV, Osborne CK, Schiff R. The changing role of ER in endocrine resistance. Breast. In press.
• Hertz DL, Snavely AC, McLeod HL, Walko CM, Ibrahim JG, Anderson S, Weck KE, Magrinat G, Olajide O, Moore S, Raab R, Carrizosa DR, Corso S, Schwartz G, Peppercorn JM, Evans JP, Jones DR, Desta Z, Flockhart DA, Carey LA, Irvin WJ Jr. In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles. Br J Clin Pharmacol 2015 Apr 24. [Epub ahead of print]
• Shea T, Walko C, Chung Y, Ivanova A, Sheets J, Rao K, Gabriel D, Comeau T, Wood W, Coghill J, Armistead P, Sarantopoulos S, Serody J. Phase I/II trial of dose escalated busulfan delivered by prolonged continuous infusion in allogeneic transplant patients. Biol Blood Marrow Transplant 2015 Jul 22. [Epub ahead of print]

Invited Talks

• Christine Walko. Using multidisciplinary tumor board to augment the value of cancer sequencing. American Society of Clinical Oncology Annual Meeting; May 2015; Chicago, IL.

New ACCP Fellows

• David DeRemer

Other Notable Achievements

• Saeed K. Alzghari: Began an oncology-focused PGY1 Pharmacy Practice Residency at Baylor Scott & White, Temple, Texas
• Deborah A. Hass: Accepted a new position as an Oncology Pharmacist at Mt. Auburn Hospital, Cambridge, Massachusetts
• Scott Mosley: Began a fellowship with the Center for Pharmacogenomics at the University of Florida in Gainesville under the direction of Larisa Cavallari, Pharm.D., FCCP, BCPS.
• Fitri Yani: Now working as a Clinical Oncology Pharmacist at Banda Aceh, Indonesia

The HIV PRN completed its inaugural year with more than 200 trainees and members with an interest in providing HIV services and sharing resources. Members of this PRN are encouraged to come together to share their diverse clinical practices, research, education, and training experiences in order to network with other members. As a new PRN, we hope to continue to recruit new trainees and members as well as expand education and networking opportunities.

The HIV PRN has been hard at work preparing for the ACCP Global Conference on Clinical Pharmacy. Our focus session will take a look at “HIV Across the Ages.” This session will focus on perinatal, pediatric, and elderly management of HIV.

The PRN has been busy advancing clinical practice, education, and research. Notable achievements can be found below.

Promotions

• Agnes Cha: Associate Professor of Pharmacy Practice; Long Island University; Arnold & Marie Schwartz College of Pharmacy & Health Sciences

Awards

• Agnes Cha: New York State Council of Health-System Pharmacists (NYSCHP) Research and Education Foundation Infectious Diseases Research Award

Publications

• Ahmad I, Zhao X, Parameswaran S, Destache CJ, Rodriguez-Sierra J, Thoreson WB, Ahmad H, Sorrentino J, Balasubramanian S. Direct differentiation of adult ocular progenitors into striatal dopaminergic neurons. Int J Stem Cells 2015;8:106-14.
• Au TH, Destache CJ, Vivekanandan R. Hepatitis C therapy: looking toward interferon-sparing regimens. J Am Pharm Assoc (2003). 2015;55:e72-84; quiz e85-6.
• Badowski M. Infections in patients with malignancies. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2015 Book 1. Infectious Diseases. Lenexa, KS: American College of Clinical Pharmacy, 2015:143-61.
• Badowski M, Patel M. Syphilis. In: Domino F, ed. The 5-Minute Clinical Consult 2015, 23rd ed. (print, website, mobile). Philadelphia: Lippincott, Williams, & Wilkins, 2015.
• Cope R, Berkowitz L, Arcebido R, Yeh JY, Trustman N, Cha A. Evaluating the effects on an interdisciplinary practice model with pharmacist collaboration on HIV patient co-morbidities. AIDS Patient Care STDS 2015;29:445-53.
• Chiampas TD, Kim H, Badowski M. Evaluation of the occurrence and type of antiretroviral and opportunistic infection medication errors within the inpatient setting. Pharm Pract (Granada) 2015;13:512.
• Date AA, Shibata A, Bruck P, Destache CJ. Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates. Biomed Chromatogr 2015;29:709-15.
• Kovarova M, Council OD, Date AA, Long J, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Nanoformulations of rilpivirine for topical pericoital and systemic coital-independent administration efficiently prevent HIV transmission. PLoS Pathogen 2015.
• Li Q, Tso FY, Kang G, Fan W, Lu W, Li Y, Yuan Z, Destache CJ, Wood C. Early antiretroviral therapy prevents the establishment of HIV-1 infection in humanized-BLT mice. JAIDS 2015;69:519-27.
• Mandal S, Zhou Y, Shibata A, Destache CJ. Confocal fluorescence microscopy: an ultra-sensitive tool used to evaluate intracellular antiretroviral nano-drug delivery in HeLa cells. AIP Adv 2015;5:084803.
• Miller MM, Liedtke MD, Lockhart SM, Rathbun RC. The role of dolutegravir in the management of HIV infection. Pineda LJ, Mercier RC, Dilworth T, Iandiorio M, Rankin S, Jakeman B. Evaluating community pharmacists’ HIV testing knowledge: a cross-sectional survey. J Am Pharm Assoc (2003). 2015;55:424-8.
• Wang T, Hoag SW, Eng ML, Polli J, Pandit NS. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies. J Clin Pharm Ther 2015;40:68-75.
• Tesh LD, Shaeer KM, Cho JC, Estrada SJ, Huang V, Bland CM, Paul DiMondi V, Potter AN, Hussein G, Brandon Bookstaver P. Neisseria gonorrhoeae and fosfomycin: past, present and future. Int J Antimicrob Agents 2015 Jun 19.

Poster Presentations

• Merker A, Badowski M, Perez S, Vu B, Vaughn P, Young J, Shicker L, Patel M. Evaluation of safety and efficacy of first-line antiretroviral single tablet regimens (STR) in the correctional setting: is one tablet once daily the best option? European Society of Clinical Microbiology and Infectious Diseases Annual Meeting; April 26, 2015; Copenhagen, Denmark. P0535.
• Patel M, Badowski M, Shicker L, Vaughn P, Young J. Efficacy and safety of an efavirenz-containing regimen in the management of human immunodeficiency virus (HIV) in a psychiatric prison population. European Society of Clinical Microbiology and Infectious Diseases Annual Meeting; April 26, 2015; Copenhagen, Denmark. P0570.
• Del Bello D, Bichoupan K, Levine C, Cha A, Perlman D, Salomon NH, Kotler D, Fierer DS, Dieterich DT, Branch AD. Real-world data on HIV-positive patients with HCV treated with sofosbuvir and/or simeprevir. Conference of Retroviruses and Opportunistic Infections; Seattle WA.

Publications

• Dick TB, Lindberg LS, Ramirez DD, Charlton MR. A clinician’s guide to drug-drug interactions with direct acting antiviral agents for the treatment of hepatitis C virus infection. Hepatology 2015 May 29. [Epub ahead of print]
• Gabardi S, Asipenko N, Fleming J, et al. Evaluation of low- versus high-dose valganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients. Transplantation 2015.
• Maldonado AQ, Tichy E, Rogers CC, Campara M, Ensor C, Doligalski C, Gabardi S, Descourouez J, Doyle I, Trofe-Clark J. Assessing pharmacologic and non-pharmacologic risk in kidney transplant recipients. Am J Health Syst Pharm 2015;72:781-93.
• Pennington CA, Park JM. Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. Am J Health Syst Pharm 2015;72:277-84.
• Connelly J, Pilch N, Oliver M, Jordan C, Fleming J, et al. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant 2015;19:555-62.
• Rendulic T, Ramon DS, Killen PD, Samaniego-Picota M, Park JM. Chapter 22. Beyond criteria and definitions: outcomes of a standardized antibody-mediated rejection protocol with a diagnostic schema different from the Banff 2009 criteria. In: Everly MJ, Terasaki PI, eds. Clinical Transplants 2014. Los Angeles: Terasaki Foundation Laboratory, 2015:179-87.
• Wang XX, Feng MR, Nguyen H, Smith DE, Cibrik DM, Park JM. Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis. Eur J Clin Pharmacol 2015;71:673-9.
• Taber DJ, Pilch NA, Trofe-Clark J, Kaiser TE. A national survey assessing the current workforce of transplant pharmacists across accredited U.S. solid organ transplant programs. Am J Transplant 2015 May 18. [Epub ahead of print]
• Trofe-Clark J, Kaiser TK, Pilch N, Taber D. Value of solid organ transplant-trained pharmacists in transplant infectious diseases. Curr Infect Dis Rep 2015;17:475.
• Stevens DR, Sawinski D, Blumberg E, Bloom RD, Trofe-Clark J. Response to: Lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff. Transplant Infect Dis 2015 Apr 28. [Epub ahead of print]

Presentations

• Boyle K, Fleming JN, Taber D, et.al. Mycophenolate dose reductions contribute to suboptimal graft outcomes in kidney transplant recipients. Poster presentation. American Transplant Congress; May 5, 2015; Philadelphia, PA.
• Casale J, Fleming JN, Taber D, et.al. Induction with interleukin-2 receptor antagonist in sensitized adult kidney transplant recipients is highly effective and safe. Poster presentation. American Transplant Congress; May 2, 2015; Philadelphia, PA.
• Casale J, Fleming JN, Taber D, et.al. Effectiveness of protocol-driven induction therapy in adult kidney transplant recipients. Oral presentation. American Transplant Congress; May 4, 2015; Philadelphia, PA.
• Travis Dick: Management case study: are you getting the most value from your decentralized staffing model? Midyear Clinical Meeting; 2015; New Orleans, LA.
• Fleming JN, Taber D, Pilch N, et.al. mTOR-based CNI minimization vs. withdrawal in African American kidney transplant recipients. Poster presentation. American Transplant Congress; May 5, 2015; Philadelphia, PA.
• Fleming JN, Taber D, Pilch N, et.al. Maximizing peri-operative value-based care in kidney transplant induction. Poster presentation. American Transplant Congress; May 2, 2015; Philadelphia, PA.
• Covert K, Fleming JN, Taber D, et.al. Patient and process-level factors associated with kidney transplant readmissions. Oral presentation. American Transplant Congress; May 4, 2015; Philadelphia, PA.
• Reese PR, Bloom RD, Trofe-Clark J, Mussell A, Leidy D, Levsky S, Zhu J, Lin Y, Troxel A, Feldman H, Volpp K. Customized reminders and provider notification to improve adherence to immunosuppression. Accepted as a poster presentation at: American Transplant Congress Meeting; May 2015; Philadelphia, PA. Awarded as a Poster of Distinction.
• Jennifer Trofe-Clark: Invited presenter for Immunology/Transplantation PRN Focus Session: Novel Approaches to Immunomodulation: The future of immunosuppression is now! American College of Clinical Pharmacy Global Conference on Pharmacy; October 2015; San Francisco, CA.
• Trofe-Clark J, Brennan D, West-Thielke P, Milone MC, Lim MA, Bloom RD. Comparison of pharmacokinetics and pharmacogenomics of once-daily extended-release MeltDose® tacrolimus tablets (Envarsus® XR) vs. twice-daily tacrolimus capsules in stable African American kidney transplant patients: a randomized cross-over study. Accepted as a poster presentation at: American Transplant Congress Meeting; May 2015; Philadelphia, PA.
• Trofe-Clark J, Brennan D, West-Thielke P, Milone MC, Lim MA, Bloom RD. A randomized cross-over phase 3b study of the pharmacokinetics of once-daily extended release MeltDose® tacrolimus (Envarsus® XR) versus twice-daily tacrolimus in African-Americans (ASERTAA). Accepted as a poster presentation at: American Transplant Congress Meeting; May 2015; Philadelphia, PA. Awarded as a Poster of Distinction.
• Trofe-Clark J, Brennan D, West-Thielke P, Milone MC, Lim MA, Bloom RD. A randomized cross-over phase 3b study of the pharmacokinetics of once-daily extended release MeltDose® tacrolimus (Envarsus® XR) versus twice-daily tacrolimus in African-Americans (ASERTAA) quality of life and adherence. Accepted as a brief oral presentation at: 17th Congress of the European Society for Organ Transplantation; September 2015; Brussels, Belgium.
• Trofe-Clark J, Brennan D, West-Thielke P, Milone MC, Lim MA, Bloom RD. PK and pharmacogenomics of once-daily-Meltdose® tacrolimus (Envarsus® XR) vs twice-daily tacrolimus: a randomized cross-over study in stable African American kidney transplant patients (ASERTAA). Accepted as a brief oral presentation at: 17th Congress of the European Society for Organ Transplantation; September 2015; Brussels, Belgium.

Awards

• Jennifer Trofe-Clark: Fellow of American Society of Transplantation

Appointments

• James Fleming: Journal Editorial Board – Clinical Transplantation

Introduction

The Infectious Diseases PRN (ID-PRN) continues to grow, with more than 2300 members, including 843 trainees. The ID-PRN has four active committees (Programming, Nominations, Awards, and Publications), which are working diligently to support and encourage membership involvement through meeting schedules, development of new Awards and recognition categories for our members, and development of a PRN newsletter. The ID-PRN is excited to offer three awards this year: a Clinical Practice Award, a Distinguished Investigator Award, and Distinguished Research Trainee Travel Awards (two student awardees and two resident/fellow awardees) that will be announced before the Global Conference. The ID-PRN provided partial tuition scholarships to three of its members (Ivy Ge, Merlin Punnoose, and Young Lee) to attend the Mentored Research Investigator Training (MeRIT) program.

Two ID-PRN members were elected Fellows of ACCP, and they will be honored during the Global Conference in San Francisco, California. The ID-PRN congratulates:

• Kerry LaPlante, Providence, RI
• R. Chris Rathbun, Oklahoma City, OK

Promotions

• Brandon Dionne: Completed PGY2 Pharmacy Residency in Infectious Diseases and started new position as Assistant Professor at Midwestern University College of Pharmacy – Glendale
• Chris Frei: Program Director, Translational Science Ph.D. Program, The University of Texas at Austin, The University of Texas Health Science Center, The University of Texas San Antonio, and The University of Texas School of Public Health San Antonio Regional Campus
• Kayla Stover: Tenured and Promoted to Associate Professor of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS

Awards

• Chris Frei: P3 Class Teaching Excellence Award, College of Pharmacy, The University of Texas at Austin
• Chris Frei: Outstanding Faculty Member of the Year, Phi Lambda Sigma, College of Pharmacy, The University of Texas at Austin
• Ivy Ge: 2015 Mentored Research Investigator Training (MeRIT) Program ID-PRN Scholarship recipient
• Michael Klepser: Ferris State University Academic Scholar Award
• Michael Klepser: American College of Clinical Pharmacy Clinical Practice Award
• Michael Klepser: Excellence in Innovation Award. Michigan Pharmacists Association
• Young Lee: 2015 Mentored Research Investigator Training (MeRIT) Program ID-PRN Scholarship recipient
• Lucas Okumura: Best Paper, Student, Resident or Fellow Award, American College of Clinical Pharmacy (2015 Virtual Symposium)
• Merlin Punnoose: 2015 Mentored Research Investigator Training (MeRIT) Program ID-PRN Scholarship recipient
• Velliyur Viswesh: Teacher of the Year Award (Infectious Diseases Pharmacotherapy), California Northstate University College of Pharmacy

Grants

• Chris Destache: Long-acting antiretroviral nanoparticles for HIV prophylaxis. National Institute of Allergy and Infectious Diseases (NIAID) R01AI117740-01 $2,157,930. 2015–2019
• Michael Klepser: Implementation and evaluation of a community pharmacy-based pharmacist-physician collaborative hepatitis C screening program with linkage to care. National Association of Chain Drug Stores Foundation. $25,000.00. December 2014
• Michael Klepser: Implementation and evaluation of an innovative community pharmacy-based HIV and HCV screening program and linkage to care. National Association of Chain Drug Stores Foundation. $500,000. (Donald G. Klepser, Ph.D., Principal Investigator.) July 2015

Publications

• Aitken SL, Alam MJ, Khaleduzzuman M, Walk ST, Musick WL, Pham VP, Christensen J, Atmar RL, Xie Y, Garey KW. In the endemic setting, Clostridium difficile ribotype 027 is virulent but not hypervirulent. Infect Control Hosp Epidemiol. Accepted June 18, 2015. In press.
• Aitken SL, Altshuler J, Guervil DJ, Hirsch EB, Ostrosky-Zeichner LL, Ericsson CD, Tam VH. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with gram-negative bacterial pneumonia. Int J Antimicrob Agents 2015;45:541-4.
• Aitken SL, Tichy EM. Clinical use of rhesus immune globulin products to prevent alloimmunization during pregnancy: a primer for the health-systems pharmacist [review]. Am J Health Syst Pharm 2015;72:267-76.
• Argamany JR, Aitken SL, Lee GC, Boyd NK, Reveles KR. Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001 to 2010. Am J Infect Control 2015;43:435-40.
• Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci 2015;349:316-20.
• Pham VP, Luce AM, Ruppelt SC, Wei W, Aitken SL, Musick WL, Roux R, Garey KW. Age-stratified treatment response rates in hospitalized patients with Clostridium difficile infection treated with metronidazole. Antimicrob Agents Chemotherapy. [Epub ahead of print]
• Phe K, Cadle RM, Guervil DJ, Guzman OE, Lockwood AM, Perez KK, Vuong NN, Aitken SL. Significant Publications on infectious diseases Pharmacotherapy in 2014 (review). Am J Health Syst Pharm. In press.
• Bland CM, Bookstaver PB. Double gram-positive coverage for acute bacterial skin and skin structure infections: has the eagle landed? Clin Infect Dis 2015 Jun 16.
• Bookstaver DA, Bland CM, Arroyo MA. Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates. J Med Microbiol 2015.
• Cho JC, Sharma RS, Sutton DA, Wiederhold NP, Sanders C, Wickes BL, Estrada SJ. Fungal arthritis secondary to Colletotrichum gloeosporioides. JMM Case Rep 2015.
• Cho JC, Fiorenza MA, Estrada SJ. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination. Pharmacotherapy 2015;35:701-15.
• Tesh LD, Shaeer KM, Cho JC, Estrada SJ, Huang V, Bland CM, Dimondi VP, Potter A, Hussein G, Bookstaver PB. Neisseria gonorrhoeae and fosfomycin: past, present, and future. Int J Antimicrob Agents 2015 Jun 19.
• Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, Reyes K, Zervos MJ. Clinical outcomes of daptomycin for vancomycin-resistant Enterococcus bacteremia. Clin Ther 2015 May 14.
• Pettit NN, DePestel DD, Fohl AL, Eyler R, Carver PL. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection. Pharmacotherapy 2015;35:119-26.
• Li Q, Tso FY, Kang G, Fan W, Lu W, Li Y, Yuan Z, Destache CJ, Wood C. Early antiretroviral therapy prevents the establishment of HIV-1 infection in humanized-BLT mice. JAIDS 2015;69:519-27.
• Mandal S, Zhou Y, Shibata A, Destache CJ. Confocal fluorescence microscopy: an ultra-sensitive tool used to evaluate intracellular antiretroviral nano-drug delivery in HeLa cells. AIP Advances. 2015;8. http://dx.doi.org/10.1063/1.4926584.
• Dionne B, Neff L, Lee SA, Sutton DA, Wiederhold NP, Lindner J, Fan H, Jakeman B. Pulmonary fungal infection caused by Neoscytalidium dimidiatum. J Clin Microbiol. 2015;53:2381-84.
• Ali SK, Reveles KR, Davis R, Mortensen EM, Frei CR, Mansi I. The association of statin use and gonado-sexual function in women: a retrospective cohort analysis. J Sex Med 2015;12:83-92.
• Badillo R, Schmidt R, Mortensen EM, Frei CR, Mansi I. Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching. Pharmacoepidemiol Drug Saf 2015;24:849-57.
• Davis R, Reveles KR, Ali SK, Mortensen EM, Frei CR, Mansi I. Statins and male sexual health: a retrospective cohort analysis. J Sex Med 2015;12:158-67.
• Khalil D, Boktor M, Mortensen EM, Frei CR, Mansi I. Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers. Am J Cardiol 2015;115:1396-401.
• Mansi I, Frei CR, Wang CP, Mortensen EM. Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults. J Gen Intern Med 2015.
• Walk ME, Mehta A, Katipally B, Frei CR, Du LC. Integrating a physical therapist into the urgent care team: an administrative case study of a collaborative, seamless, and cost-effective care pathway for neuromusculoskeletal problems. Phys Ther J Pol Admin Leadership 2015;15:J1-J13.
• Kitazono H, Rog D, Grim SA, Clark NM, Reid GE. Acinetobacter baumannii infection in solid organ transplant recipients. Clin Transplant 2015;29:227-32.
• Barber KE, King ST, Stover KR, Pogue JM. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Rev Anti Infect Ther 2015;13:363-77.
• Klepser ME, Adams AJ, Klepser DG. Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance. Health Secur 2015;13:166-73.
• Akinwale TP, Adams AJ, Dering-Anderson AM, Klepser ME. Pharmacy-based point-of-care testing for infectious diseases: considerations for the pharmacy curriculum. Curr Pharm Teach Learn 2015;7:131-6.
• Darin KM, Klepser ME, Klepser DG, Klepser SA, Reeves A, Young M, Scarsi KK. Pharmacist-provided rapid HIV testing in two community pharmacies. J Am Pharm Assoc 2015;55:81-8.
• Duanis D, Klepser ME, Ogrin BJ. Assessment of pharmacy students’ and licensed pharmacists’ perceived knowledge, application, and interpretation regarding rapid diagnostic tests (RDTs) for infectious diseases. Curr Pharm Teach Learn 2015;7:100-5.
• Huang V, Klepser ME, Gubbins PO, Bergman SJ, Chahine EB, Halilovic J, Hidayat LK, Matthias KR, Tesh LD. Quantification of curricular content devoted to point-of-care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharm Ed 2015;15:1-6.
• Klepser DG, Corn CE, Dering-Anderson AM, Schmidt M, Klepser ME. Healthcare resource utilization and costs for influenza-like illness among Midwestern health plan members. J Manag Care Spec Pharm 2015;21:568-73.
• Labreche MJ, Graber CJ, Nguyen HM. Recent updates on the role of pharmacokinetics-pharmacodynamics in antimicrobial susceptibility testing as applied to clinical practice. Clin Infect Dis 2015 June. [Epub ahead of print]
• Reveles KR, Juday TR, Labreche MJ, et al. Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients. PLoS One 2015;10:e0120953.
• Reveles KR, Juday TR, Labreche MJ, Mortensent EM, Koeller JM, Seekins D, Oramasionwu SU, Bollinger M, Copeland LA, Jones X, Frei CR. Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients. PLoS One 2015;10:e0120953.
• Lee GC, Long SW, Musser JM, et al. Comparative whole genome sequencing of community-associated methicillin-resistant Staphylococcus aureus sequence type 8 from primary care clinics in a Texas community. Pharmacotherapy 2015;35:220-8.
• Okumura LM, Gomes-Da-Silva M, Veroneze I. Effects of a bundled antimicrobial stewardship program on mortality: a cohort study. Braz J Infect Dis 2015;19:246-52.
• Guarascio AJ, Slain D. Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole. Pharmacotherapy 2015;35:208-19.
• Turner RB, Slain D, Petros K, Keller LA, Sarwari AR.Clinical outcomes following hospital-wide implementation of prolonged-infusion cefepime and ceftazidime. Int J Antimicrob Agents 2015;46:129-30.
• Stover KR, Cleary JD. Cardiac response to centrally administered echinocandin antifungals. J Pharm Pharmacol 2015;67:1279-83.
• Stover KR, Cleary JD. The eagle-like effect of the echinocandins: is it relevant for clinical decisions? Curr Fung Infect Rep 2015;9:88-93.
• Chastain DB, Henderson H, Stover KR. Antiretroviral-associated cardiovascular disease. Open AIDS J 2015;9:23-37.
• Viswesh V, Yost SE, Kaplan B. The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: a systematic review. Transplant Rev 2015;29:175-80.

New ACCP Fellows

• Kerry LaPlante
• R. Chris Rathbun

Other Notable Achievements

• Chris Bland: Fellow of the Infectious Diseases Society of America (IDSA). Fellowship in IDSA honors those who have achieved professional excellence and provided significant service to the profession.
• Brandon Bookstaver: Named to the South Carolina Governor’s Committee for Pharmacist Immunization Expansion
• Jason Gallagher: Fellow of the Infectious Diseases Society of America (IDSA). Fellowship in IDSA honors those who have achieved professional excellence and provided significant service to the profession.
• Michael Klepser: Co-developer of “Community Pharmacy-Based Point-of-Care Testing Certificate Program.” The program was recently acquired by NACDS. Since May, more than 600 pharmacists have gone through the certificate program, and around 400 have become trained trainers.
• Kristi Kuper: Invited attendee at the White House’s Forum on Antibiotic Stewardship, held in Washington, D.C., on June 2. The event brought together key representatives from the public and private sector to discuss the role of antimicrobial stewardship in reducing the national and global threat of antibiotic resistance.
• Tim Pasquale: Fellow of the Infectious Diseases Society of America (IDSA). Fellowship in IDSA honors those who have achieved professional excellence and provided significant service to the profession.

Introduction

The Nephrology PRN Programming Committee has planned an excellent session for the 2015 Global Conference on Clinical Pharmacy on “Treatment of Kidney Disease in Special Populations” to be held Monday, October 19, 1:30 pm. – 3:00 p.m. Our business meeting and networking forum will be held the evening of Tuesday, October 20. We continue to stay active in the Kidney Health Initiative through the American Society of Nephrology and recently submitted a recommendation of Dr. Wendy St. Peter for appointment to the Board of Directors. Several PRN members were also able to gather and network at the National Kidney Foundation Spring Clinical Meetings in addition to doing several posters and platform presentations.

Promotions

• Melanie S. Joy: Associate Professor with Tenure at University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences

Awards

• Ifeanyi Onor: 2015 AACP Walmart Scholars Program Faculty Mentor
• Nicole M. Wegrzyn: Runner-up for Teacher of the Year for AY 2014–15 at Pacific University Oregon School of Pharmacy

Grants

• El-Masri M, El Nekidy W, Kadri A. A randomized double-blind controlled study to compare the effectiveness of 1.0 versus 2.0 mg alteplase (tPA) dosing in restoring hemodialysis catheter function. The Kidney Foundation of Canada. ($91,960) Co-principal investigator – 2014–2016. https://clinicaltrials.gov/ct2/show/NCT02225782
• St. Peter W. Kam-Chen research grant for $70,000 for “Refining Population Management Criteria to Optimize Return on Investment of Medication Management Services in Care Transitions”

Publications

• Malkinska M, El Nekidy W, El-Masri M, Kadri A, Donaldson C, Soong D. Traditional versus once weekly intravenous iron therapy in hemodialysis patients. Poster Presentation. 2014 Canadian Society of Nephrology Annual General Meeting. Vancouver, British Columbia, Canada.
• Nyman HA. Renal dosing in high-risk populations. J Infus Nurs 2015;38:210-5.
• Okogbaa JI, Onor IO, Arije OA, Harris MB, Lillis RA. Phenytoin-induced purple glove syndrome: a case report and review of the literature. Hosp Pharm 2015;50:391-5.

Other Notable Achievements

• Lori Wazny: Appointed to the board of the Canadian Society of Hospital Pharmacists Research and Education Foundation for a 3-year term
• Nicole M. Wegrzyn: Offered a position as PGY2 Nephrology Resident with Albany College of Pharmacy and Health Sciences

Introduction

The Pain and Palliative Care PRN members continue to receive recognition for their accomplishments in publications, promotions, and other areas of achievement.

Promotions

• Jayne Pawasauskas: Clinical Professor at the University of Rhode Island College of Pharmacy

Publications

• Rennick A, Atkinson TJ, Cimino NM, Strassels SA, McPherson ML, Fudin J. Variability in opioid equivalence calculations. Pain Med 2015. In press.
• DiScala SL, Lese M. Chronic pain. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2015 Book 2. CNS/Pharmacy Practice. Lenexa, KS: American College of Clinical Pharmacy, 2015:99-124.
• Fudin J. New Naloxone Technologies to Reduce Opioid Overdose Fatalities in Medscape. July 31, 2015. Available at www.medscape.org/viewarticle/844947. Accessed August 3, 2015.
• Fudin J. The economics of opioids: abuse, REMS, and treatment benefits. Part 3 of Continuing education module – Use of Opioid Analgesics in Managed Care Practice: Challenges, Controversies, REMS, and Optimizing Patient Management for your review. August 2015;21:S165-S196.
• Fudin J. Hydrocodone metabolism [letter to the editor]. Pract Pain Manage 2014;14:12-4.
• Fudin J, Kominek C. Naloxegol descheduled. Pract Pain Manage 2015.
• Ahmed N, Horlacher RJ, Pham T, Fudin J. Adrenergic agonists and sympatholytic agents in the prevention or treatment of opioid withdrawal. Pract Pain Manage 2015;15(6). In press.
• Atkinson TJ, Fudin J, Pham TC. Combined fentanyl and methadone induced serotonin syndrome is called into question [letter to the editor]. Pharmacotherapy 2015;35:e111-e113.
• Gudin J, Laitman A, Fudin J, Kominek C. Combating opioid-induced constipation: new and emerging therapies. Pract Pain Manage 2014;14:41-8.
• Linares OA, Daly D, Fudin J, Daly-Linares A, Stefanovski D, Boston RC. Individualized hydrocodone therapy based on phenotype, pharmacogenetics, and pharmacokinetic dosing. Clin J Pain 2015 Jan 23. Early release.
• Linares OA, Fudin J, Daly-Linares A, Schiesser WE, Boston RC. Methadone recycling sustains drug reservoir in tissue. J Pain Palliat Care Pharmacotherapy 2015. In press.
• Linares OA, Fudin J, Schiesser WE, Daly-Linares AL, Boston RC. CYP2D6 phenotype-specific codeine population pharmacokinetics. J Pain Palliat Care Pharmacotherapy 2015; early online: 1-12.
• Linares O, Michel T, Fudin J, Boston RC, Daly AM. Integrating clinical pharmacokinetics, pharmacogenetics, and quantitative cytochrome P450 polymorphic gene drug-drug interactions (DDIs). Pain Physician 2015;18:E439-E446.
• Linares OA, Schiesser WE, Fudin J, Pham TC, Bettinger JJ, Mathew RO, Daly-Linares A. In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis. J Pain Res 2015;8:417-29.
• Pham TC, Fudin J, Desai AP, Faxon JL. Neuropathy in HIV patients: pain concerns. Pract Pain Manage 2015;15;41-7.
• Pham TC, Fudin J, Raffa RB. Is levorphanol a better option than methadone? Pain Med 2015. In press.
• Tennant F, Guess S, Gudin J, Fudin J. Rationale for medical management. Pract Pain Manage 2015;15:36-44.
• Dispennette RS, Hall LA, Elliott DP. Activities of palliative care and pain management clinical pharmacists. Am J Health Syst Pharm 2015;72:999-1000.
• Matson KL, Pawasauskas J, Procopio F. Reported behaviors of prescription drug misuse and medication safety among students attending a Rhode Island university. R I Med 2015;98:37-40.
• Pruskowski J, Arnold RM. Pregabalin in palliative care #288. J Palliat Med 2015;18:299-300.
• Pruskowski J, Arnold RM. A comparison of pregabalin and gabapentin in palliative care #289. J Palliat Med 2015;18:386-7.
• Pruskowski J, Arnold RM. Tramadol in palliative care #290. J Palliat Med 2015;18:461-2.
• Ventura MM, Brittain K, Pruskowski J, Hogan D, Walker T. Development of an age-dependent antibiogram in a veterans affairs community. J Am Geriatr Soc 2015;63:186-8.
• Afrane M, Sera L, Holmes HH, McPherson ML. Commonly prescribed medications among patients in hospice care for chronic obstructive pulmonary disease. Am J Hospice Palliat Care 2015; Early online publication.

Posters/Abstracts

• Rennick A, Atkinson TJ, Cimino N, Fudin J, Strassel S, McPherson ML. Variability in opioid equivalence. P44 at the International Conference on Opioids. Harvard Medical School; June 8, 2015; Boston, MA.
• Fudin J, Shahzad N, Jarrett NWD, Pham TC, Prouty E. Development of an immunoassay urine drug screen app for interpreting unexpected results. P15 at the International Conference on Opioids. Harvard Medical School; June 7, 2015; Boston, MA.
• Desai A, Pham T, Fudin J. Comparative retrospective to prospective analysis of clinician reliability and cost effectiveness for accurately interpreting urine drug screens (UDS) for patients receiving chronic opioid therapy. (Poster: 1-101). American Society of Health-System Pharmacists (ASHP) 2014 Midyear Clinical Meeting and Exhibition; Anaheim, CA.
• Mahatme S, Atkinson TJ, Spallone A, Fudin J. The preliminary impact of pain management integration into an HIV specialty clinic. P4 at the International Conference on Opioids. Harvard Medical School; June 7, 2015; Boston, MA.

Other Notable Achievements

• Jeffrey Fudin: Stratton VA Medical Center Pain and Palliative Care PGY2 Residency was accredited, spring 2015
• Fudin J. Interview: new app helps interpret urine drug test results. Pract Pain Manage 2015;15:84-7.

Introduction

What a great couple of months it has been for Pediatrics! Many of the PRN members have been involved in the review courses working hard with the upcoming board certification exam. The PRN has been developing strategies to increase its membership and increase its financial stability. We received a generous donation from the Mid-Atlantic Pediatric Pharmacotherapy Specialists for $1399.80. This is very exciting, and the money will be used for various education activities throughout the year. We thank you for your generosity! We have been planning for the global conference in October and look forward to seeing everyone in San Francisco!

The Social Media Committee is continuing to post daily content to Facebook/Twitter, with up to 285 “likes” on Facebook and 60 “followers” on Twitter. As of July 1, we’ve designated specific days of the week to postings that relate to specific practice areas (Mondays = General Pediatrics, Tuesdays = NICU, and Thursdays = PICU). During the next several weeks, in addition to clinical content posts, we’ll be advertising for board exam preparation, pediatric content at the ACCP Global Conference, and PRN business (elections, business meeting at Global Conference, etc.)

The Nominations Committee put out a call for nominations for the PRN offices of chair-elect and secretary/treasurer on April 6, 2015, and received several nominations for each office. A slate was developed by the committee, and electronic balloting opened on July 10, 2015. Candidates for chair-elect are Kalen Manasco, Jennifer Hamner, and Rebecca Petitt, and candidates for secretary/treasurer are Deborah Raithel, Nick Fusco, and Jim Thigpen. Those elected to office will be notified at the end of August 2015 and will be installed at the Global Conference in October.

The Research Committee has finalized its proposal to the PBRN to conduct a project on the use of LMWH in pediatrics. The proposal, which is undergoing review, will hopefully be submitted to the PBRN soon. Once approval is obtained, the research committee will be looking for interested individuals at several institutions to join the project. Keep an eye out for updates on e-mail and Twitter and Facebook!

The Travel Awards Committee issued a call for applications for the Pediatric PRN Student and Resident/Fellow Travel Awards during summer 2015. The PRN offers one student and one resident/fellow award ($1000 per award) each year to support attendance to the ACCP Annual Meeting. Applications are under review, and the selected applicants will present their research as part of the Pediatrics PRN business meeting at the 2015 ACCP Global Conference.

The Paper Committee is still in the editing phase of the paper titled “The Value of the Pediatric Clinical Pharmacist.” We hope to complete this phase soon. We are also in the development phase of an update to the 2005 pediatric education article.

The Education Committee has been hard at work planning the educational activities for the Global Conference in October. It will be a great session, and all are invited to attend. The Education Committee has also been restructured to begin working on educational sessions throughout the year.

The Professional Advancement Committee has been designing a brochure for students and residents to increase their involvement in organizations.

Awards

• Kimberly J. Novak: 2015 Pharmacist of the Year award by the Ohio Society of Health-System Pharmacists

Grants

• Peter N. Johnson: Pediatric Pharmacy Advocacy Group Neonatal Grant (2014–2015)—Primary investigator is Kaitlin Hughes: Peter N. Johnson – Coinvestigator. Grant title: “Comparison of Amikacin Pharmacokinetics in Neonates Pre- and Post- – A Dosing Protocol Change”
• Allison Lardieri, Jill Morgan: Cumberland Pharmaceuticals Grant: “Stability of Lactulose (Kristalose) Compared to Polyethylene Glycol (Miralax) at Varying Time Points and in Common Liquids”

Publications

• Fusco NM, Parbuoni KA, Morgan JA. Time to first antibiotic administration after onset of sepsis in critically ill children. J Pediatr Pharmacol Ther 2015;20:37-44.
• Fusco NM, Toussaint K, Prescott WA Jr. Antibiotic treatment of MRSA pulmonary exacerbations in pediatric and adult patients with cystic fibrosis. Ann Pharmac Other 2015;49:458-68.
• Hoff DS, Chicella M, Cies JJ, Hansen L. Critical care. In: Chow J, Lubsch L, eds. PPAG: Pediatric PharmPrep Advanced Guide (book online). 2015. Available at https://ppagu.benchprep.com/.
• Hoff DS, Lipnik PG, Lissick JR. Congenital heart disease. In: Eiland L, Todd T, eds. Advanced Pediatric Therapeutics. Memphis: Pediatric Pharmacy Advocacy Group, 2015.
• Taylor JL, Liu M, Hoff DS. Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema. J Pediatr Pharmacol Ther 2015;20:128-37.
• Wu TT, Hoff DS. Fish oil lipid emulsion associated sea-blue histiocyte syndrome in a pediatric patient. J Pediatr Pharmacol Ther 2015;20:217-21.
• Chandler C, Miller JL, Cunnyngham C, Johnson PN. Propylene glycol-induced lactic acidosis in a child receiving a pentobarbital continuous infusion. J Pediatr Intensive Care 2014;3:73-7. [Case Report]
• Miller M, Burton MB, Johnson PN, Miller JL. “Once-daily” versus “extended-interval” administration of aminoglycosides in neonates: need for standard terminology. Am J Health Syst Pharm 2014;71:2108-9. [Letter]
• Miller MM, Johnson PN, Hagemann TM, Carter SM, Miller JL. Pseudohyperphosphatemia in pediatric patients prescribed liposomal amphotericin. Am J Health Syst Pharm 2014;71:1462-8. [Original Research]
• Lardieri AB, Fusco NM, Simone S, Walker K, Morgan JA, Parbuoni KA. Effects of clonidine on withdrawal from long-term dexmedetomidine in the pediatric patient. J Pediatr Pharmacol Ther 2015;20:45-53.
• LaRochelle JM. PICU I. Pediatric Pharmacy Preparatory Review Course, Vol 1. American College of Clinical Pharmacy, 2015.
• LaRochelle JM. Trauma. In: Eiland L, Todd T, eds. Advanced Pediatric Therapeutics. Memphis: Pediatric Pharmacy Advocacy Group, 2015.
• LaRochelle JM, Desselle B. Critical care Pharmacotherapy: description of an innovative pediatric residency elective experience utilizing clinical pharmacy faculty as preceptor. Crit Care Shock 2015;18:52-4.
• Parrish RH II, Cernak I. Creating a distinct medication-use system for children at the point of care: the time is now. Pharmacy 2015;3:72-8.
• So TY. Pediatric medication dosing. Pediatrics for Parents 2015;30:24-5.
• Saneeymehri S, Baker K, So TY. Overview of pharmacological treatment options for pediatric patients with refractory Kawasaki disease. J Pediatr Pharmacol Ther 2015;20:163-77.

Other Notable Achievements

• Kimberly Novak: Secretary of PPAG

Introduction

The Perioperative Care PRN was established in October 2014 to provide education and resources related to the overall management of perioperative patients, to address the regulatory requirements imposed by accrediting bodies, and to provide a place for members to discuss complicated perioperative patients and seek input and recommendations on care.

The ACCP Perioperative Care PRN strives to address common concerns associated with pre-, inter-, and postoperative phases of care as they relate to patient-specific parameters (age, sex, and comorbid conditions) and medical severity. The scope of this network includes addressing underlying disease processes and progression, successfully managing sedation and pain, identifying alterations in drug disposition (administration, absorption, distribution, metabolism, and excretion), and using evidence-based medicine to evaluate and minimize surgical complications. The goal of this network is to incorporate interdisciplinary collaboration through academia, research, and practice development while ensuring safe and effective perioperative management of all patient populations.

The ACCP Perioperative Care PRN encourages members to interact through the e-mail list and the ACCP Perioperative Care PRN Facebook group available at https://www.facebook.com/#!/groups/742181659164330/. We will be hosting the PRN’s introductory business meeting on Monday, October 19, and the first focus session titled “Perioperative Care: Balancing the Scales Between Bleeding and Clotting” on October 20 at the 2015 Global Conference in San Francisco, California. The Perioperative Care PRN’s inaugural focus session aims to provide advanced information on the delicate balance between bleeding and adequate hemostasis in specialized surgical patient populations. The topics include hemostatic agents for hemophiliac patients undergoing surgery, drug therapy concerns and controversies of the new oral anticoagulants throughout the surgical spectrum, and special considerations surrounding patients receiving neuroaxial analgesia. This program will use both didactic teaching and case studies to educate the audience. Please join us on Tuesday, October 20, from 1:30 p.m. to 3:00 p.m. For more information about the session, please visit www.accp.com/meetings/gc15/schedule.aspx?mode=detail&i=4850&from=schedule.

Promotions

• Marian Gaviola: Assistant Professor at UNT System College of Pharmacy

Grants

• Marian Gaviola: ACCP Critical Care PRN Resident Research Grant, October 2014

Awards

• Stacey Bortlik (Moultrie): UF Health Shands Children’s Hospital Medication Safety Great Catch Award in April 2015. The great catch event was highlighted internally on the Bridge by https://bridge.ufhealth.org/blog/safety/pharmacist-and-nurses-prevent-a-pediatric-patient-from-receiving-wrong-form-of-drug/.

Publications

• Parrish RH II, Cernak I. Creating a distinct medication-use system for children at the point of care: the time is now. Pharmacy (Special Issue – Pharmacy Paediatrics) 2015;3:72-8 (refereed). Available at www.mdpi.com/2226-4787/3/3/72/htm.
• April Smith: Book chapters published in Patient Assessment in Pharmacy Practice, 3rd ed. Philadelphia: Wolters Kluwer, 2016: Chapter 14. Gastrointestinal system. 255-75; Chapter 15. Hepatic System. 276-92.

Other Notable Achievements

• Kara L. Birrer: Perioperative Care PRN Chair-Elect
• Stacey Bortlik (Moultrie): Florida Board of Pharmacy Consultant Pharmacist License
• Herbert “Matt” Mathews: Perioperative Care PRN Treasurer
• Richard Parrish: Perioperative Care PRN Secretary
• April Smith: Presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) Weekend Meeting held June 25–28, 2015, in Las Vegas, Nevada. Dr. Smith’s presentations were (1) Pharmacological Treatment of Obesity and (2) Perioperative Pharmacology in the Bariatric Surgery Patient: Who, What, Where, Why All the Prep?

Publications

• Arwood MJ, Cavallari LH, Duarte JD. Pharmacogenomics of hypertension and heart disease. Curr Hypertens Rep 2015;17:586.
• Best BM, Burchett SK, Li H, Stek A, Hu C, Wang J, Hawkins E, Byroads M, Watts DH, Smith E, Fletcher CV, Capparelli EV, Mirochnick M, P1026s Team. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med 2015;16:502-11.
• Colbers A, Best B, Schalkwijk S, Wang J, Stek A, Tenorio CH, Hawkins D, Taylor G, Kreitchmann R, Burchett S, Haber A, Kabamba K, van Kasteren M, Smith E, Capparelli E, Burger D, Mirochnick M, the PANNA Network and the IMPAACT 1026s Study Team. Maraviroc pharmacokinetics in HIV-1 infected pregnant women. Clin Infect Dis 2015 Jul 22. [Epub ahead of print]
• Stek A, Best BM, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, Cressey TR, Mofenson LM, Smith E, Shapiro D, Mirochnick M, IMPAACT P1026s Protocol Team. Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women. J Acquir Immune Defic Syndr 2015 May 6. [Epub ahead of print]
• Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee I. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther 2015;98:19-24.
• Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther 2015 May 13. [Epub ahead of print]
• Saito Y, Stamp LK, Caudle KE, Hershfield M, McDonagh EM, Callaghan JT, Tassaneeyakul W, Mushiroda T, Kamatani N, Goldspiel BR, Phillips EJ, Klein TE, Lee MT. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharmacol Ther 2015 Jun 10. [Epub ahead of print]
• Crews KR, Caudle KE, Dunnenberger HM, Sadhasivam S, Skaar TC. Considerations for the utility of the CPIC guideline for CYP2D6 genotype and codeine therapy. Clin Chem 2015;61:775-6.
• Dunnenberger HM, Crews KR, Hoffman JM, Caudle KE, Broeckel U, Howard SC, Hunkler RJ, Klein TE, Evans WE, Relling MV. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol 2015;55:89-106.
• Elewa H, El-Mekaty E, El-Bardissy A, Ensom MHH, Wilby KJ. Therapeutic drug monitoring of voriconazole: a critical review of current evidence for measuring drug concentrations for treatment or prevention of invasive fungal infections. Clin Pharmacokinet 2015 Jun 13. [Epub ahead of print]
• Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, Edwards S, Ensom MHH, Foster DR, Hardy B, Kiser T, La Porte C, Roberts J, Shulman R, Walker S, Zelenitsky S, Moher D. Reporting guidelines for clinical pharmacokinetic studies. The ClinPK Statement. Clin Pharmacokinet 2015;54:783-95.
• Kiang TKL, Wilby KJ, Ensom MHH. A comprehensive, critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of the novel 5th-generation cephalosporin, ceftaroline. Clin Pharmacokinet 2015 May 5. [Epub ahead of print]
• Rainkie D, Ensom MHH, Carr RR. Pediatric assessment of vancomycin empiric dosing (PAVED): a retrospective review. Pediatr Drugs 2015;17:245-53.
• Reardon J, Lau TTY, Ensom MHH. Vancomycin loading doses: a systematic review. Ann Pharmacotherapy 2015;49:557-65.
• Wilby KJ, Shabana S, Ensom MHH, Marra F. A critical review of the current evidence for measuring drug concentrations of first-line agents used to treat tuberculosis in children. Clin Pharmacokinet 2015 Jul 16. [Epub ahead of print]
• Hussein G. Forensic toxicology. In: Rajat S, ed. Toxicology: The Past, Present, and Future of Basic, Clinical, and Forensic Medicine. Hauppauge, NY: Nova Science Publishers, 2015. Final draft accepted May 2015.
• Hussein G. Forensic analysis of medication errors, adverse drug events, and drug labeling changes. In: Rajat S, ed. Toxicology: The Past, Present, and Future of Basic, Clinical, and Forensic Medicine. Hauppauge, NY: Nova Science Publishers, 2015. Final draft accepted May 2015.
• Tesh LD, Shaeer KM, Cho JC, Estrada SJ, Huang V, Bland CM, DiMondi CP, Potter AN, Hussein G, Bookstaver PB. Neisseria gonorrhoeae and fosfomycin: past, present, and future. Int J Antimicrob Agents 2015;46:292-8.

Abstracts Presented

• Hussein G, Khalil O. Analysis of prescription drug labeling changes from January 2004 to December 2013. American Pharmacists Association (APhA) Annual Meeting; March 27–30 2015; San Diego, CA.
• Hussein G, Lay K. Co-curricular activity to enhance patient assessment and pharmacy-physician assistant (PA) telephonic interaction. Abstract presented at: AACP Annual Meeting; July 11–15, 2015; National Harbor, MD.
• Hussein G, Weller M, Redmond K, Kirby B, Grigsby C, Fathy R. Evaluation of drugs removed from the United States market from 2000 to 2013. 74th World Congress of Pharmacy and Pharmaceutical Sciences (FIP); August 31 – September 4, 2014; Bangkok, Thailand.
• Bond S, Hussein G. An analysis of over-the-counter products (OTC) products marketed in the United States with the inclusion of undeclared prescription ingredients from 2002 to 2013. ASHP Midyear Clinical Meeting; December 7–10, 2014; Anaheim, CA.
• Clubb B, Smyth N, Hussein G. Evaluation of prescription drugs that require individualized dosing and monitoring in patients with hepatic impairment. ASHP Midyear Clinical Meeting; December 7–10, 2014; Anaheim, CA.

Other Notable Achievements

• Mary H.H. Ensom: One of four individuals inducted into the inaugural class of the Hall of Distinguished Alumni, University of Kentucky College of Pharmacy. The other honorees were Drs. Bob Blouin, Bob Rapp, and Salomon Stavchansky. See http://pharmacy.mc.uky.edu/display.php?id=1135: College Inducts First Class in Hall of Distinguished Alumni John E. Murphy: Received the Robert K Chalmers Distinguished Educator award from AACP in July
• Keith Moore: Issued three patents recently (i.e., US Patent Nos. 9,060,939, 8,968,777, and 8,957,113), directed to modified release oral tranexamic acid formulations that preferably minimize or eliminate undesirable gastrointestinal side effects to improve patient compliance with therapy, and the methods of treatment with these formulations, for women with heavy menstrual bleeding when administered two or three times per day

PRN Update

The Women’s Health PRN now has 300 total members, including 160 students, 10 residents, and 1 fellow.

We would like to welcome the following new members: Sarah Abel, Jessica Adamski, Daniel Aistrope, Jennifer Bajoka, Sarah Derr, Kaylyn DesRosier, Christine Echtenkamp, Allison Englert, Randa Fahim, Jamie Fery, Krista Gatto, Kristin Gramith, Sarah Hayes, Bonnie Hooten, Lindsay Jackson, Sefa Kploanyi, Anne Lau, Caitlin Leach, Jamie Lukasiewicz, Anthony Oladipo, Ijeoma Onyema, Sarah Payne, Penny Sarah, Sofia Shim, Abigail Taylor, Ariel Thurmer, Kevin Vu, BethanyWattengel, C. Edwin Webb, Shannon White, and Nicole Williams.

We are continuing our trainee Travel Awards and developing additional awards, including the Vital Contributions to Women’s Health Award, Research Mini-Grant, and Associate/Full Member Travel Award.

The Women’s Health PRN focus session titled “Healthy Mom, Healthy Baby: Best Practices in Optimizing Preconception Health and Pregnancy Outcomes” will be held Monday from 1:30 p.m. to 3:00 p.m. We look forward to seeing current and prospective members at the Women’s Health PRN business and networking meeting on Monday from 6 p.m. to 9 p.m.

Awards

• Nicole Cieri: Faculty Preceptor of the Year
• Nicole Cieri: Pharmacy Practice Faculty of the Year
• Nicole Cieri: The Spirit of Saint Marguerite Service Award in recognition of Healthy Buffalo
• Sarah McBane: National Community Pharmacists Association Leadership Award

Grants

• Sally Rafie: Research mini-grant from The National Campaign to Prevent Teen and Unplanned Pregnancies to study older teen attitudes toward access to birth control in pharmacies

Publications

• Ahmed N, Okoli C, Ainsworth J. Ineffective central nervous system HIV suppression of once-a-day maraviroc and ritonavir booster darunavir dual therapy: four case reports. Int J STD AIDS 2015. [Epub]
• Simasek M, Ballard SL, Phelps P, et al. Meeting resident scholarly activity requirements through a longitudinal quality improvement curriculum. J Grad Med Educ 2015;7:86-90.
• Briggs GG, Polifka JE, Wisner KL, Gervais E, Miller RK, Berard A, Koren G, Forinash A, Towers CV. Should pregnant women be included in phase IV clinical drug trials? Am J Obstet Gynecol 2015.
• DeMarco L, Panzarella K, Ferro H, Pownall L, Case A, Nowakowski P, Stewart M, Duszkiewicz A, Verni C, Kennedy M, Cieri N, Dowd C, Dunford D. Outcomes of an interprofessional simulation curriculum. J Appl Res Higher Educ 2015.
• Scultz P, Fery J, Lampkin SJ, Cieri NE. Misoprostol patients misunderstood: how to manage patients with miscarriages. Inside Patient Care Pharmacy and Clinics. May 2015;15-9.
• McAdam-Marx C, Dahal A, Jennings B, Singhal M, Gunning K. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes. J Mang Care Spec Pharm 2015;21:452-68.
• Pillai VC, Han K, Beigi RH, Hankins GD, Clark S, Hebert MF, et al. Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women. Br J Clin Pharmacol 2015. [Epub]
• Der-Nigoghossian CA, Eldebs M, Karaoui LR, Saad A. Hints for success in ASHP’s clinical skills competition. Am J Health Syst Pharm 2015;72:434-5.
• McBane S. Scheduling good health: pharmacists as primary immunizers. Pharmacy Times, Directions in Pharmacy. May 18, 2015. Link.
• McBane SE, Dopp AL, Abe A, Benavides S, Chester EA, Dixon DL, Dunn M, Johnson MD, Nigro SJ, Rothrock-Christian T, Schwartz AH, Thrasher K, Walker S. Collaborative drug therapy management and comprehensive medication management – 2015. Pharmacotherapy 2015;35:e39-50.
• McClendon KS, Bell AM, Ellis A, et al. Pathways to improve student pharmacists’ experience in research. Am J Pharm Educ 2015;79:58.
• Rafie S. Updates in contraception. Ambulatory Care Self-Assessment Program (ACSAP) 2015, Book 2, Women’s and Men’s Care.
• Raney EC. What new therapeutic options exist for the relief of menopausal symptoms? JAAPA 2015;28:14-6.
• Shealy KM. Are antidepressants safe in the first trimester of pregnancy? JAAPA 2015;28:16-7.
• Clements JN, Shealy KM. Liraglutide: an injectable option for the management of obesity. Ann Pharmacotherpy 2015;49:938-44.
• Shrader S, Dunn B, Blake E, Phillips C. Incorporating standardized colleague simulations in a clinical assessment course and evaluating the impact on inter professional education. Am J Pharm Educ 2015;79:57.
• Shrader S, Mauldin M, Hammad S, Mitcham M, Blue A. Developing a comprehensive faculty development program to promote interprofessional education, practice and research at a free-standing academic health science center. J Interprof Care 2015;29:165-7.
• Maxwell WD, Shrader SP, Moore KG, Lu ZK, White SF. Survey of pharmacists’ subtherapeutic INR management and anticoagulation bridging practices. J Clin Pharm Ther 2015. [Epub]
• Stone RH. Management of chronic conditions in pregnancy. Ambulatory Care Self-Assessment Program (ACSAP) 2015 Book 2, Women’s and Men’s Care.

News Article Features

• McBane S. Over-the-counter birth control pills will soon be available in California. KPBS. July 22, 2015. Link
• McBane S. Pharmacists take on broader role. The San Diego Union-Tribune. June 15, 2015. Link
• Rafie S. 10 Surprising facts about contraception. Everyday Health. May 15, 2015. Link
• Rafie S. 10 Best birth control methods. Lady Lux. March 2, 2015. Link
• Rafie S. 12 secrets every pharmacist knows (and you should, too). Prevention. April 6, 2015. Link
• Rafie S. California to let pharmacists prescribe birth control pills. Healthline. June 26, 2015. Link

Other Notable Achievements

• Sarah McBane: President of the California Pharmacists Association
• Kim Thrasher: Panelist at “Health is Primary” event sponsored by Family Medicine for America’s Health
• Kevin Vu: Poster titled “Pharmacist Intentions to Participate in Pharmacy Access to Hormonal Contraception in California” at the American Pharmacists Association Annual Meeting